1
|
Nouwade K, Tfaili S, Prost B, Dakroub H, Solgadi A, Libong D, Paul JL, Fournier N, Chaminade P. Comprehensive analysis of oxylipins using reverse phase liquid chromatography and data dependent acquisition workflow on LTQ-Orbitrap® Velos Pro. Talanta 2024; 266:124921. [PMID: 37454517 DOI: 10.1016/j.talanta.2023.124921] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Revised: 06/25/2023] [Accepted: 07/05/2023] [Indexed: 07/18/2023]
Abstract
Oxylipins - involved in inflammatory processes - are reported in several diseases, in biological, pharmacological, and physiological fields. To face the structural complexity of oxylipins, the study of isomers and isobars species relied on Selected Reaction Monitoring (SRM) and Multiple Reaction Monitoring (MRM) in tandem mass spectrometry such as triple quadrupole, quadrupole-Time of Flight (TOF). Unfortunately, false positive signals in cellular matrix could occur using MRM or SRM mode since the MS/MS spectrum of each molecule is not acquired with the previous mode to help molecule confirmation. Using the versatile ability of LTQ-Orbitrap® Velos Pro mass spectrometer, we developed a novel method based on data dependent acquisition (DDA) workflow for oxylipins analysis. To reach sufficient data points per peak and a better sensitivity to quantify oxylipins traces, an optimization of the acquisition frequency was carried out both on linear trap and Orbitrap analyzers. A segmentation of the chromatographic profile and an optimization of the collision energies by HCD (higher energy collision dissociation) for each eicosanoid increased the acquisition frequency significantly and the detection threshold: around 2 pg for some prostanoids and 0.02-2 pg for some leukotrienes and oxidized species. We validated our method in terms of specificity (RSD <10%), sensitivity, accuracy and precision. The intra and inter-day accuracy were between 86.56% and 114.93%. Besides, a relative standard deviation less than 15% as intra- and inter-day precision were obtained for almost all molecules. A linear range between 2.5 and 12,500 pg was reached. DDA approach on LTQ-Orbitrap® constitutes an alternative to MRM mode on triple quadrupole for eicosanoids quantification in complex matrices. Finally, this method helped us to compare for the first time the amount of prostanoids released by J774 and THP-1 macrophages under lipopolysaccharide (LPS) stimulation.
Collapse
Affiliation(s)
- Kodjo Nouwade
- Lip(Sys)(2) - Chimie Analytique Pharmaceutique, UFR Pharmacie, Université Paris-Saclay, Orsay, France
| | - Sana Tfaili
- Lip(Sys)(2) - Chimie Analytique Pharmaceutique, UFR Pharmacie, Université Paris-Saclay, Orsay, France.
| | - Bastien Prost
- UMS-IPSIT SAMM Facility, Université Paris-Saclay, Inserm, CNRS, Ingénierie et Plateformes au Service de l'Innovation Thérapeutique, UFR Pharmacie, Orsay, France
| | - Hani Dakroub
- Lip(Sys)(2) - Equipe «athérosclérose et macrophages: impact des phospholipides et des fonctions mitochondriales sur le trafic et l'efflux du cholestérol cellulaire», UFR Pharmacie, Université Paris-Saclay, Orsay, France
| | - Audrey Solgadi
- UMS-IPSIT SAMM Facility, Université Paris-Saclay, Inserm, CNRS, Ingénierie et Plateformes au Service de l'Innovation Thérapeutique, UFR Pharmacie, Orsay, France
| | - Danielle Libong
- Lip(Sys)(2) - Chimie Analytique Pharmaceutique, UFR Pharmacie, Université Paris-Saclay, Orsay, France; UMS-IPSIT SAMM Facility, Université Paris-Saclay, Inserm, CNRS, Ingénierie et Plateformes au Service de l'Innovation Thérapeutique, UFR Pharmacie, Orsay, France
| | - Jean-Louis Paul
- Lip(Sys)(2) - Equipe «athérosclérose et macrophages: impact des phospholipides et des fonctions mitochondriales sur le trafic et l'efflux du cholestérol cellulaire», UFR Pharmacie, Université Paris-Saclay, Orsay, France
| | - Natalie Fournier
- Lip(Sys)(2) - Equipe «athérosclérose et macrophages: impact des phospholipides et des fonctions mitochondriales sur le trafic et l'efflux du cholestérol cellulaire», UFR Pharmacie, Université Paris-Saclay, Orsay, France
| | - Pierre Chaminade
- Lip(Sys)(2) - Chimie Analytique Pharmaceutique, UFR Pharmacie, Université Paris-Saclay, Orsay, France; UMS-IPSIT SAMM Facility, Université Paris-Saclay, Inserm, CNRS, Ingénierie et Plateformes au Service de l'Innovation Thérapeutique, UFR Pharmacie, Orsay, France
| |
Collapse
|
2
|
Marcelino HR, Solgadi A, Chéron M, do Egito EST, Ponchel G. Exploring the permeability of Amphotericin B trough serum albumin dispersions and lipid nanocarriers for oral delivery. Int J Pharm 2023; 646:123444. [PMID: 37757958 DOI: 10.1016/j.ijpharm.2023.123444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2023] [Revised: 08/12/2023] [Accepted: 09/20/2023] [Indexed: 09/29/2023]
Abstract
Amphotericin B (AmB) is a potent polyenic antifungal agent with leishmanicidal activity. Due to its low solubility and permeability in the gastrointestinal tract, AmB is usually administered intravenously. In this context, various approaches have been used to try to improve these properties. Some of the systems developed have shown proven successful, but there is still a lack of knowledge about the pathways AmB takes after oral administration. Therefore, the aim of this work was not only to obtain aqueous dispersions containing AmB at different aggregation states, but also to entrap this molecule in nanocarriers, and evaluate the influence of these conditions on the jejunal permeability of AmB. To observe the aggregation states of AmB, physicochemical characterization of AmB-albumin complexes and AmB-loaded formulations was performed. Different degrees of AmB aggregation states were obtained. Thus, permeability tests were performed in the Ussing chamber and a decrease in AmB concentration in the donor compartment was observed. Electrophysiological measurements showed different responses depending on the AmB formulation. In conclusion, although control of the AmB aggregation state was observed by physicochemical characterization, this approach does not seem to have a sufficient effect on AmB permeability, but on its toxicity. For a complete understanding of AmB-loaded nanocarriers, other pathways, such as lymphatic absorption, should also be investigated.
Collapse
Affiliation(s)
- Henrique Rodrigues Marcelino
- Graduate Program in Health Sciences (PPgCSa), Federal University of Rio Grande do Norte, Natal/RN 59012-570, Brazil; Institut Galien Paris-Saclay, CNRS UMR 8612, Université Paris-Saclay, Orsay 91190, France; College of Pharmacy, Federal University of Bahia, Salvador/BA 40170-115, Brazil (Recent affiliation)
| | - Audrey Solgadi
- SFR IPSIT (Paris-Saclay Institute of Therapeutic Innovation), University Paris-Saclay, Orsay 91190, France
| | - Monique Chéron
- College of Pharmacy, University Paris-Saclay, Orsay 91190, France
| | | | - Gilles Ponchel
- Institut Galien Paris-Saclay, CNRS UMR 8612, Université Paris-Saclay, Orsay 91190, France; College of Pharmacy, University Paris-Saclay, Orsay 91190, France
| |
Collapse
|
3
|
Khadhraoui N, Prola A, Vandestienne A, Blondelle J, Guillaud L, Courtin G, Bodak M, Prost B, Huet H, Wintrebert M, Péchoux C, Solgadi A, Relaix F, Tiret L, Pilot-Storck F. Hacd2 deficiency in mice leads to an early and lethal mitochondrial disease. Mol Metab 2023; 69:101677. [PMID: 36693621 PMCID: PMC9986742 DOI: 10.1016/j.molmet.2023.101677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/05/2022] [Revised: 01/13/2023] [Accepted: 01/13/2023] [Indexed: 01/22/2023] Open
Abstract
OBJECTIVE Mitochondria fuel most animal cells with ATP, ensuring proper energetic metabolism of organs. Early and extensive mitochondrial dysfunction often leads to severe disorders through multiorgan failure. Hacd2 gene encodes an enzyme involved in very long chain fatty acid (C ≥ 18) synthesis, yet its roles in vivo remain poorly understood. Since mitochondria function relies on specific properties of their membranes conferred by a particular phospholipid composition, we investigated if Hacd2 gene participates to mitochondrial integrity. METHODS We generated two mouse models, the first one leading to a partial knockdown of Hacd2 expression and the second one, to a complete knockout of Hacd2 expression. We performed an in-depth analysis of the associated phenotypes, from whole organism to molecular scale. RESULTS Thanks to these models, we show that Hacd2 displays an early and broad expression, and that its deficiency in mice is lethal. Specifically, partial knockdown of Hacd2 expression leads to death within one to four weeks after birth, from a sudden growth arrest followed by cachexia and lethargy. The total knockout of Hacd2 is even more severe, characterized by embryonic lethality around E9.5 following developmental arrest and pronounced cardiovascular malformations. In-depth mechanistic analysis revealed that Hacd2 deficiency causes altered mitochondrial efficiency and ultrastructure, as well as accumulation of oxidized cardiolipin. CONCLUSIONS Altogether, these data indicate that the Hacd2 gene is essential for energetic metabolism during embryonic and postnatal development, acting through the control of proper mitochondrial organization and function.
Collapse
Affiliation(s)
- Nahed Khadhraoui
- Univ Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France; EnvA, IMRB, F-94700 Maisons-Alfort, France; EFS, IMRB, F-94010 Créteil, France
| | - Alexandre Prola
- Univ Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France; EnvA, IMRB, F-94700 Maisons-Alfort, France; EFS, IMRB, F-94010 Créteil, France
| | - Aymeline Vandestienne
- Univ Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France; EnvA, IMRB, F-94700 Maisons-Alfort, France; EFS, IMRB, F-94010 Créteil, France
| | - Jordan Blondelle
- Univ Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France; EnvA, IMRB, F-94700 Maisons-Alfort, France; EFS, IMRB, F-94010 Créteil, France
| | - Laurent Guillaud
- Univ Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France; EnvA, IMRB, F-94700 Maisons-Alfort, France; EFS, IMRB, F-94010 Créteil, France
| | - Guillaume Courtin
- Univ Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France; EnvA, IMRB, F-94700 Maisons-Alfort, France; EFS, IMRB, F-94010 Créteil, France
| | - Maxime Bodak
- Univ Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France; EnvA, IMRB, F-94700 Maisons-Alfort, France; EFS, IMRB, F-94010 Créteil, France
| | - Bastien Prost
- UMS IPSIT, Université Paris-Saclay, Châtenay-Malabry, F-92296, France
| | - Hélène Huet
- Biopôle, École nationale vétérinaire d'Alfort, Maisons-Alfort, F-94700, France
| | - Mélody Wintrebert
- Univ Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France; EnvA, IMRB, F-94700 Maisons-Alfort, France; EFS, IMRB, F-94010 Créteil, France
| | - Christine Péchoux
- Université Paris-Saclay, INRAE, AgroParisTech, GABI, F-78350, Jouy-en-Josas, France
| | - Audrey Solgadi
- UMS IPSIT, Université Paris-Saclay, Châtenay-Malabry, F-92296, France
| | - Frédéric Relaix
- Univ Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France; EnvA, IMRB, F-94700 Maisons-Alfort, France; EFS, IMRB, F-94010 Créteil, France
| | - Laurent Tiret
- Univ Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France; EnvA, IMRB, F-94700 Maisons-Alfort, France; EFS, IMRB, F-94010 Créteil, France.
| | - Fanny Pilot-Storck
- Univ Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France; EnvA, IMRB, F-94700 Maisons-Alfort, France; EFS, IMRB, F-94010 Créteil, France.
| |
Collapse
|
4
|
Bargui R, Solgadi A, Dumont F, Prost B, Vadrot N, Filipe A, Ho ATV, Ferreiro A, Moulin M. Sex-Specific Patterns of Diaphragm Phospholipid Content and Remodeling during Aging and in a Model of SELENON-Related Myopathy. Biomedicines 2023; 11:biomedicines11020234. [PMID: 36830771 PMCID: PMC9953087 DOI: 10.3390/biomedicines11020234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2022] [Revised: 01/13/2023] [Accepted: 01/13/2023] [Indexed: 01/19/2023] Open
Abstract
Growing evidence shows that the lipid bilayer is a key site for membrane interactions and signal transduction. Surprisingly, phospholipids have not been widely studied in skeletal muscles, although mutations in genes involved in their biosynthesis have been associated with muscular diseases. Using mass spectrometry, we performed a phospholipidomic profiling in the diaphragm of male and female, young and aged, wild type and SelenoN knock-out mice, the murine model of an early-onset inherited myopathy with severe diaphragmatic dysfunction. We identified 191 phospholipid (PL) species and revealed an important sexual dimorphism in PLs in the diaphragm, with almost 60% of them being significantly different between male and female animals. In addition, 40% of phospholipids presented significant age-related differences. Interestingly, SELENON protein absence was responsible for remodeling of 10% PL content, completely different in males and in females. Expression of genes encoding enzymes involved in PL remodeling was higher in males compared to females. These results establish the diaphragm PL map and highlight an important PL remodeling pattern depending on sex, aging and partly on genotype. These differences in PL profile may contribute to the identification of biomarkers associated with muscular diseases and muscle aging.
Collapse
Affiliation(s)
- Rezlène Bargui
- Basic and Translational Myology Laboratory, Université Paris Cité, BFA, CNRS UMR8251, F-75013 Paris, France
| | - Audrey Solgadi
- UMS-IPSIT-SAMM, Université Paris-Saclay, INSERM, CNRS, Ingénierie et Plateformes au Service de l’Innovation Thérapeutique, F-91400 Orsay, France
| | - Florent Dumont
- UMS-IPSIT-Bioinfo, Université Paris-Saclay, INSERM, CNRS, Ingénierie et Plateformes au Service de l’Innovation Thérapeutique, F-91400 Orsay, France
| | - Bastien Prost
- UMS-IPSIT-SAMM, Université Paris-Saclay, INSERM, CNRS, Ingénierie et Plateformes au Service de l’Innovation Thérapeutique, F-91400 Orsay, France
| | - Nathalie Vadrot
- Basic and Translational Myology Laboratory, Université Paris Cité, BFA, CNRS UMR8251, F-75013 Paris, France
| | - Anne Filipe
- Basic and Translational Myology Laboratory, Université Paris Cité, BFA, CNRS UMR8251, F-75013 Paris, France
| | - Andrew T. V. Ho
- Basic and Translational Myology Laboratory, Université Paris Cité, BFA, CNRS UMR8251, F-75013 Paris, France
| | - Ana Ferreiro
- Basic and Translational Myology Laboratory, Université Paris Cité, BFA, CNRS UMR8251, F-75013 Paris, France
- AP-HP, Reference Centre for Neuromuscular Disorders, Institut of Myology, Neuromyology Department, Pitié-Salpêtrière Hospital, F-75013 Paris, France
| | - Maryline Moulin
- Basic and Translational Myology Laboratory, Université Paris Cité, BFA, CNRS UMR8251, F-75013 Paris, France
- Correspondence: ; Tel.: +01-57-27-79-54
| |
Collapse
|
5
|
Bouchema TSE, Annereau M, Vieillard V, Boquet R, Coelho GA, Castelli F, Solgadi A, Paul M, Yagoubi N, Secretan PH, Do B. Identification of the Major Degradation Pathways of Selumetinib. Pharmaceutics 2022; 14:pharmaceutics14122651. [PMID: 36559146 PMCID: PMC9787286 DOI: 10.3390/pharmaceutics14122651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2022] [Revised: 11/25/2022] [Accepted: 11/27/2022] [Indexed: 12/05/2022] Open
Abstract
Selumetinib is administered orally in capsule form and is indicated for the treatment of neurofibromatosis. To facilitate dosage adjustments, liquid preparations, such as solutions or suspensions, are to be developed. This led, first, to determine the stability profile of soluble or dispersed selumetinib and, secondly, to look for ways to stabilize the active substance. The degradation kinetics of selumetinib as a function of stress conditions were determined and compared. The degradation products were detected and identified by LC-HRMSn. In solution, selumetinib is sensitive to oxidation and degrades by photooxidation. In both cases, the side chain represented by the oxoamide group is concerned, leading to the formation of an amide derivative for the first case and an ester derivative for the second. The identification of such degradation mechanisms allowed us to study, in a targeted way, processes aiming at stabilizing the active molecule.
Collapse
Affiliation(s)
| | - Maxime Annereau
- Matériaux et Santé, Université Paris-Saclay, 91400 Orsay, France
- Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 114 Rue Edouard Vaillant, 94800 Villejuif, France
| | - Victoire Vieillard
- Department of Pharmacy, Henri Mondor Hospital, AP-HP, 94000 Créteil, France
| | - Raphael Boquet
- Department of Pharmacy, Henri Mondor Hospital, AP-HP, 94000 Créteil, France
| | | | - Florence Castelli
- Département Médicaments et Technologies pour la Santé (DMTS), MetaboHUB, CEA, INRAE, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - Audrey Solgadi
- Ingénierie et Plateformes au Service de l’Innovation Thérapeutique, Inserm, CNRS, Université Paris-Saclay, 92296 Châtenay-Malabry, France
| | - Muriel Paul
- Department of Pharmacy, Henri Mondor Hospital, AP-HP, 94000 Créteil, France
- EpidermE, Université Paris Est Creteil, 94010 Creteil, France
| | - Najet Yagoubi
- Matériaux et Santé, Université Paris-Saclay, 91400 Orsay, France
| | | | - Bernard Do
- Matériaux et Santé, Université Paris-Saclay, 91400 Orsay, France
- Department of Pharmacy, Henri Mondor Hospital, AP-HP, 94000 Créteil, France
| |
Collapse
|
6
|
Marconnet A, Michon B, Prost B, Solgadi A, Le Bon C, Giusti F, Tribet C, Zoonens M. Influence of Hydrophobic Groups Attached to Amphipathic Polymers on the Solubilization of Membrane Proteins along with Their Lipids. Anal Chem 2022; 94:14151-14158. [PMID: 36200347 DOI: 10.1021/acs.analchem.2c01746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
One of the biggest challenges in membrane protein (MP) research is to secure physiologically relevant structural and functional information after extracting MPs from their native membrane. Amphipathic polymers represent attractive alternatives to detergents for stabilizing MPs in aqueous solutions. The predominant polymers used in MP biochemistry and biophysics are amphipols (APols), one class of which, styrene maleic acid (SMA) copolymers and their derivatives, has proven particularly efficient at MP extraction. In order to examine the relationship between the chemical structure of the polymers and their ability to extract MPs from membranes, we have developed two novel classes of APols bearing either cycloalkane or aryl (aromatic) rings, named CyclAPols and ArylAPols, respectively. The effect on solubilization of such parameters as the density of hydrophobic groups, the number of carbon atoms and their arrangement in the hydrophobic moieties, as well as the charge density of the polymers was evaluated. The membrane-solubilizing efficiency of the SMAs, CyclAPols, and ArylAPols was compared using as models (i) two MPs, BmrA and a GFP-fused version of LacY, overexpressed in the inner membrane of Escherichia coli, and (ii) bacteriorhodopsin, naturally expressed in the purple membrane of Halobacterium salinarum. This analysis shows that, as compared to SMAs, the novel APols feature an improved efficiency at extracting MPs while preserving native protein-lipid interactions.
Collapse
Affiliation(s)
- Anaïs Marconnet
- Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, CNRS, UMR 7099, Université Paris Cité, F-75005 Paris, France.,Fondation Edmond de Rothschild pour le développement de la recherche scientifique, Institut de Biologie Physico-Chimique, F-75005 Paris, France
| | - Baptiste Michon
- Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, CNRS, UMR 7099, Université Paris Cité, F-75005 Paris, France.,Fondation Edmond de Rothschild pour le développement de la recherche scientifique, Institut de Biologie Physico-Chimique, F-75005 Paris, France
| | - Bastien Prost
- UMS-IPSIT SAMM, Inserm, CNRS, Ingénierie et Plateformes au Service de l'Innovation Thérapeutique, Université Paris-Saclay, F-92296 Châtenay-Malabry, France
| | - Audrey Solgadi
- UMS-IPSIT SAMM, Inserm, CNRS, Ingénierie et Plateformes au Service de l'Innovation Thérapeutique, Université Paris-Saclay, F-92296 Châtenay-Malabry, France
| | - Christel Le Bon
- Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, CNRS, UMR 7099, Université Paris Cité, F-75005 Paris, France.,Fondation Edmond de Rothschild pour le développement de la recherche scientifique, Institut de Biologie Physico-Chimique, F-75005 Paris, France
| | - Fabrice Giusti
- Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, CNRS, UMR 7099, Université Paris Cité, F-75005 Paris, France.,Fondation Edmond de Rothschild pour le développement de la recherche scientifique, Institut de Biologie Physico-Chimique, F-75005 Paris, France
| | - Christophe Tribet
- P.A.S.T.E.U.R., Département de Chimie, École Normale Supérieure, PSL University, CNRS, Sorbonne Université, F-75005 Paris, France
| | - Manuela Zoonens
- Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, CNRS, UMR 7099, Université Paris Cité, F-75005 Paris, France.,Fondation Edmond de Rothschild pour le développement de la recherche scientifique, Institut de Biologie Physico-Chimique, F-75005 Paris, France
| |
Collapse
|
7
|
Abreu S, Héron S, Solgadi A, Prost B, Dalloux-Chioccioli J, Kermarrec A, Meynier A, Bertrand-Michel J, Tchapla A, Chaminade P. Rapid assessment of fatty acyls chains of phospholipids and plasmalogens by atmospheric pressure chemical ionization in positive mode and high-resolution mass spectrometry using in-source generated monoacylglycerol like fragments intensities. J Chromatogr A 2022; 1673:463093. [DOI: 10.1016/j.chroma.2022.463093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2022] [Revised: 04/23/2022] [Accepted: 04/25/2022] [Indexed: 10/18/2022]
|
8
|
Coppens E, Desmaële D, Naret T, Garcia-Argote S, Feuillastre S, Pieters G, Cailleau C, Paul JL, Prost B, Solgadi A, Michel JP, Noiray M, Couvreur P, Mura S. Gemcitabine lipid prodrug nanoparticles: Switching the lipid moiety and changing the fate in the bloodstream. Int J Pharm 2021; 609:121076. [PMID: 34481886 DOI: 10.1016/j.ijpharm.2021.121076] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Revised: 08/30/2021] [Accepted: 08/31/2021] [Indexed: 10/20/2022]
Abstract
A simple approach to achieve a lipoprotein (LP)-mediated drug delivery is to trigger the spontaneous drug insertion into endogenous lipoproteins in the bloodstream, by means of its chemical modification. Nanoparticles (NPs) made of the squalene-gemcitabine (SQGem) conjugate were found to have a high affinity for plasma lipoproteins while free gemcitabine did not, suggesting a key role of the lipid moiety in this event. Whether the drug conjugation to cholesterol, one of the major lipoprotein-transported lipids, could also promote an analogous interaction was a matter of question. NPs made of the cholesterol-gemcitabine conjugate (CholGem) have been herein thoroughly investigated for their blood distribution profile both in vitro and in vivo. Unexpectedly, contrarily to SQGem, no trace of the CholGem prodrug could be found in the lipoprotein fractions, nor was it interacting with albumin. The investigation of isolated NPs and NPs/LPs physical mixtures provided a further insight into the lack of interaction of CholGem NPs with LPs. Although essential for allowing the self-assembly of the prodrug into nanoparticles, the lipid moiety may not be sufficient to elicit interaction of the conjugated drug with plasma lipoproteins but the whole NP physicochemical features must be carefully considered.
Collapse
Affiliation(s)
- Eleonore Coppens
- Institut Galien Paris-Saclay, UMR 8612, CNRS, Université Paris-Saclay, Faculté de Pharmacie, 5 rue Jean-Baptiste Clément, F-92296 Châtenay-Malabry cedex, France
| | - Didier Desmaële
- Institut Galien Paris-Saclay, UMR 8612, CNRS, Université Paris-Saclay, Faculté de Pharmacie, 5 rue Jean-Baptiste Clément, F-92296 Châtenay-Malabry cedex, France
| | - Timothée Naret
- Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SCBM, Bat 547, 91191 Gif-sur-Yvette, France
| | - Sébastien Garcia-Argote
- Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SCBM, Bat 547, 91191 Gif-sur-Yvette, France
| | - Sophie Feuillastre
- Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SCBM, Bat 547, 91191 Gif-sur-Yvette, France
| | - Grégory Pieters
- Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SCBM, Bat 547, 91191 Gif-sur-Yvette, France
| | - Catherine Cailleau
- Institut Galien Paris-Saclay, UMR 8612, CNRS, Université Paris-Saclay, Faculté de Pharmacie, 5 rue Jean-Baptiste Clément, F-92296 Châtenay-Malabry cedex, France
| | - Jean-Louis Paul
- AP-HP, Hôpital Européen Georges Pompidou, Service de Biochimie, 75015 Paris, France; Lip(Sys)(2), Athérosclérose: homéostasie et trafic du cholestérol des macrophages, Université Paris-Saclay, Faculté de Pharmacie, 5 rue Jean-Baptiste Clément, F-92296 Châtenay-Malabry cedex, France
| | - Bastien Prost
- SAMM, UMS IPSIT, Université Paris-Saclay, Faculté de Pharmacie, 5 rue Jean-Baptiste Clément, F-92296 Châtenay-Malabry cedex, France
| | - Audrey Solgadi
- SAMM, UMS IPSIT, Université Paris-Saclay, Faculté de Pharmacie, 5 rue Jean-Baptiste Clément, F-92296 Châtenay-Malabry cedex, France
| | - Jean-Philippe Michel
- Institut Galien Paris-Saclay, UMR 8612, CNRS, Université Paris-Saclay, Faculté de Pharmacie, 5 rue Jean-Baptiste Clément, F-92296 Châtenay-Malabry cedex, France
| | - Magali Noiray
- Institut Galien Paris-Saclay, UMR 8612, CNRS, Université Paris-Saclay, Faculté de Pharmacie, 5 rue Jean-Baptiste Clément, F-92296 Châtenay-Malabry cedex, France
| | - Patrick Couvreur
- Institut Galien Paris-Saclay, UMR 8612, CNRS, Université Paris-Saclay, Faculté de Pharmacie, 5 rue Jean-Baptiste Clément, F-92296 Châtenay-Malabry cedex, France
| | - Simona Mura
- Institut Galien Paris-Saclay, UMR 8612, CNRS, Université Paris-Saclay, Faculté de Pharmacie, 5 rue Jean-Baptiste Clément, F-92296 Châtenay-Malabry cedex, France.
| |
Collapse
|
9
|
Grimbert L, Sanz MN, Gressette M, Rucker-Martin C, Novotova M, Solgadi A, Karoui A, Gomez S, Bedouet K, Jacquet E, Lemaire C, Veksler V, Mericskay M, Ventura-Clapier R, Piquereau J, Garnier A. Spatiotemporal AMPKα2 deletion in mice induces cardiac dysfunction, fibrosis and cardiolipin remodeling associated with mitochondrial dysfunction in males only. Biol Sex Differ 2021; 12:52. [PMID: 34535195 PMCID: PMC8447586 DOI: 10.1186/s13293-021-00394-z] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/26/2021] [Accepted: 08/29/2021] [Indexed: 11/13/2022] Open
Abstract
Background The AMP-activated protein kinase (AMPK) is a major regulator of cellular energetics which plays key role in acute metabolic response and in long-term adaptation to stress. Recent works have also suggested non-metabolic effects. Methods To decipher AMPK roles in the heart, we generated a cardio-specific inducible model of gene deletion of the main cardiac catalytic subunit of AMPK (Ampkα2) in mice. This allowed us to avoid the eventual impact of AMPK-KO in peripheral organs. Results Cardio-specific Ampkα2 deficiency led to a progressive left ventricular systolic dysfunction and the development of cardiac fibrosis in males. We observed a reduction in complex I-driven respiration without change in mitochondrial mass or in vitro complex I activity, associated with a rearrangement of the cardiolipins and reduced integration of complex I into the electron transport chain supercomplexes. Strikingly, none of these defects were present in females. Interestingly, suppression of estradiol signaling by ovariectomy partially mimicked the male sensitivity to AMPK loss, notably the cardiac fibrosis and the rearrangement of cardiolipins, but not the cardiac function that remained protected. Conclusion Our results confirm the close link between AMPK and cardiac mitochondrial function, but also highlight links with cardiac fibrosis. Importantly, we show that AMPK is differently involved in these processes in males and females, which may have clinical implications for the use of AMPK activators in the treatment of heart failure. AMPK is a metabolic sensor of cellular energy which regulates energy homeostasis. We generated a cardiac-specific inducible deletion of Ampkα2 and demonstrated that this deletion induces mild cardiac dysfunction in male only. Cardiac dysfunction observed in males was associated with cardiac fibrosis and cardiac cardiolipin remodeling that are not seen in females. Although no significant cardiac function alteration was noticed in ovariectomized female Ampkα2ciKO mice, these latter exhibited cardiac fibrosis and mild cardiolipins remodeling. Our results show a higher dependence on AMPK signaling fibrosis and cardiolipin biosynthesis/maturation in males, either due to the absence of female hormones protection or/and to the action of male hormones. This may contribute to the known difference in cardiovascular risk and outcome between sexes.
Collapse
Affiliation(s)
- Lucile Grimbert
- Faculté de Pharmacie, UMR-S1180, INSERM, Université Paris-Saclay, 5 rue J-B Clément, 92296, Châtenay-Malabry, France
| | - Maria-Nieves Sanz
- Faculté de Pharmacie, UMR-S1180, INSERM, Université Paris-Saclay, 5 rue J-B Clément, 92296, Châtenay-Malabry, France
| | - Mélanie Gressette
- Faculté de Pharmacie, UMR-S1180, INSERM, Université Paris-Saclay, 5 rue J-B Clément, 92296, Châtenay-Malabry, France
| | - Catherine Rucker-Martin
- Université Paris-Saclay, Inserm, Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique, 92350, Le Plessis Robinson, France
| | - Marta Novotova
- Department of Cellular Cardiology, Institute of Experimental Endocrinology, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia
| | - Audrey Solgadi
- Service d'Analyse des Médicaments et Métabolites, Université Paris-Saclay, Inserm, CNRS, Institut Paris Saclay d'Innovation Thérapeutique, 92296, Châtenay-Malabry, France
| | - Ahmed Karoui
- Faculté de Pharmacie, UMR-S1180, INSERM, Université Paris-Saclay, 5 rue J-B Clément, 92296, Châtenay-Malabry, France
| | - Susana Gomez
- Faculté de Pharmacie, UMR-S1180, INSERM, Université Paris-Saclay, 5 rue J-B Clément, 92296, Châtenay-Malabry, France
| | - Kaveen Bedouet
- Faculté de Pharmacie, UMR-S1180, INSERM, Université Paris-Saclay, 5 rue J-B Clément, 92296, Châtenay-Malabry, France
| | - Eric Jacquet
- Université Paris-Saclay, CNRS, Institut de Chimie Des Substances Naturelles, UPR 2301, 91198, Gif-sur-Yvette, France
| | - Christophe Lemaire
- Faculté de Pharmacie, UMR-S1180, INSERM, Université Paris-Saclay, 5 rue J-B Clément, 92296, Châtenay-Malabry, France.,Université Versailles St-Quentin, Université Paris-Saclay, Inserm, UMR-S 1180, 92296, Châtenay-Malabry, France
| | - Vladimir Veksler
- Faculté de Pharmacie, UMR-S1180, INSERM, Université Paris-Saclay, 5 rue J-B Clément, 92296, Châtenay-Malabry, France
| | - Mathias Mericskay
- Faculté de Pharmacie, UMR-S1180, INSERM, Université Paris-Saclay, 5 rue J-B Clément, 92296, Châtenay-Malabry, France
| | - Renée Ventura-Clapier
- Faculté de Pharmacie, UMR-S1180, INSERM, Université Paris-Saclay, 5 rue J-B Clément, 92296, Châtenay-Malabry, France
| | - Jérôme Piquereau
- Faculté de Pharmacie, UMR-S1180, INSERM, Université Paris-Saclay, 5 rue J-B Clément, 92296, Châtenay-Malabry, France.
| | - Anne Garnier
- Faculté de Pharmacie, UMR-S1180, INSERM, Université Paris-Saclay, 5 rue J-B Clément, 92296, Châtenay-Malabry, France
| |
Collapse
|
10
|
Abreu S, Heron S, Solgadi A, Joffre F, Tchapla A, Chaminade P. Rapid assessment of triacylglycerol fatty acyls composition by LC-APPI +-HRMS using monoacylglycerol like fragments intensities. Anal Chim Acta 2021; 1178:338809. [PMID: 34482865 DOI: 10.1016/j.aca.2021.338809] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2021] [Accepted: 06/27/2021] [Indexed: 11/18/2022]
Abstract
We present a new analytical approach for the analysis of triacylglycerol fatty acyls distribution by normal phase liquid chromatography (NPLC) coupled with APPI+-HRMS. The NPLC method used allows the separation of more than 30 classes of lipids. The energy of the APPI+ source enables the formation of low-intensity ions B fragments ([RC = O+74]+ <3%), characteristic of lipids with a glycerol esterified by one or more fatty acyls. We found the relative intensities of ions B were close to the fatty acyl distribution. To establish the proof of concept, we decided to focus on the triacylglycerols (TGs) class, the major component of plant oils. By either NPLC or FIA, the TGs class appeared as a single peak. In our experimental conditions, ions B are always present in the mass spectra of TGs and each ion B is specific to a fatty acyl group. The Orbitrap mass spectrometer featured high enough resolution and accuracy to identify ions B and distinguish them from other TG fragment ions. A further adjustment of the fatty acyls relative quantities calculation from ions B intensities was computed using weighting coefficients of ions B response. The methodology was developed and validated using plant oils characterized by a GC-FID reference method. NPLC-APPI+-HRMS method offers the advantage of analyzing the fatty acyl composition of complex lipid extracts without the need for sample preparation.
Collapse
Affiliation(s)
- Sonia Abreu
- Université Paris-Saclay, Lipides: Systèmes Analytiques et Biologiques, 92290, Chatenay-Malabry, France
| | - Sylvie Heron
- Université Paris-Saclay, ICP - CNRS UMR 8000, (LETIAM), 91400, Orsay, France
| | - Audrey Solgadi
- Université Paris-Saclay, Inserm, CNRS, Ingénierie et Plateformes Au Service de L'Innovation Thérapeutique, IPSIT-SAMM, 92290, Chatenay-Malabry, France
| | | | - Alain Tchapla
- Université Paris-Saclay, ICP - CNRS UMR 8000, (LETIAM), 91400, Orsay, France
| | - Pierre Chaminade
- Université Paris-Saclay, Lipides: Systèmes Analytiques et Biologiques, 92290, Chatenay-Malabry, France.
| |
Collapse
|
11
|
Prola A, Blondelle J, Vandestienne A, Piquereau J, Denis RGP, Guyot S, Chauvin H, Mourier A, Maurer M, Henry C, Khadhraoui N, Gallerne C, Molinié T, Courtin G, Guillaud L, Gressette M, Solgadi A, Dumont F, Castel J, Ternacle J, Demarquoy J, Malgoyre A, Koulmann N, Derumeaux G, Giraud MF, Joubert F, Veksler V, Luquet S, Relaix F, Tiret L, Pilot-Storck F. Cardiolipin content controls mitochondrial coupling and energetic efficiency in muscle. Sci Adv 2021; 7:7/1/eabd6322. [PMID: 33523852 PMCID: PMC7775760 DOI: 10.1126/sciadv.abd6322] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/08/2020] [Accepted: 11/04/2020] [Indexed: 05/11/2023]
Abstract
Unbalanced energy partitioning participates in the rise of obesity, a major public health concern in many countries. Increasing basal energy expenditure has been proposed as a strategy to fight obesity yet raises efficiency and safety concerns. Here, we show that mice deficient for a muscle-specific enzyme of very-long-chain fatty acid synthesis display increased basal energy expenditure and protection against high-fat diet-induced obesity. Mechanistically, muscle-specific modulation of the very-long-chain fatty acid pathway was associated with a reduced content of the inner mitochondrial membrane phospholipid cardiolipin and a blunted coupling efficiency between the respiratory chain and adenosine 5'-triphosphate (ATP) synthase, which was restored by cardiolipin enrichment. Our study reveals that selective increase of lipid oxidative capacities in skeletal muscle, through the cardiolipin-dependent lowering of mitochondrial ATP production, provides an effective option against obesity at the whole-body level.
Collapse
Affiliation(s)
- Alexandre Prola
- Université Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France
- EnvA, IMRB, F-94700 Maisons-Alfort, France
- EFS, IMRB, F-94010 Créteil, France
| | - Jordan Blondelle
- Université Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France
- EnvA, IMRB, F-94700 Maisons-Alfort, France
- EFS, IMRB, F-94010 Créteil, France
| | - Aymeline Vandestienne
- Université Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France
- EnvA, IMRB, F-94700 Maisons-Alfort, France
- EFS, IMRB, F-94010 Créteil, France
| | - Jérôme Piquereau
- UMR-S 1180, INSERM, Université Paris-Sud, Université Paris-Saclay, F-92296 Châtenay-Malabry, France
| | | | - Stéphane Guyot
- Université Bourgogne Franche-Comté, AgroSup Dijon, PAM UMR A 02.102, F-21000 Dijon, France
| | - Hadrien Chauvin
- Université Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France
- EnvA, IMRB, F-94700 Maisons-Alfort, France
- EFS, IMRB, F-94010 Créteil, France
| | - Arnaud Mourier
- Université Bordeaux, CNRS, IBGC, UMR 5095, F-33000 Bordeaux, France
| | - Marie Maurer
- Université Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France
- EnvA, IMRB, F-94700 Maisons-Alfort, France
- EFS, IMRB, F-94010 Créteil, France
| | - Céline Henry
- PAPPSO, Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, F-78350 Jouy-en-Josas, France
| | - Nahed Khadhraoui
- Université Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France
- EnvA, IMRB, F-94700 Maisons-Alfort, France
- EFS, IMRB, F-94010 Créteil, France
| | - Cindy Gallerne
- Université Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France
- EnvA, IMRB, F-94700 Maisons-Alfort, France
- EFS, IMRB, F-94010 Créteil, France
| | - Thibaut Molinié
- Université Bordeaux, CNRS, IBGC, UMR 5095, F-33000 Bordeaux, France
| | - Guillaume Courtin
- Université Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France
- EnvA, IMRB, F-94700 Maisons-Alfort, France
- EFS, IMRB, F-94010 Créteil, France
| | - Laurent Guillaud
- Université Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France
- EnvA, IMRB, F-94700 Maisons-Alfort, France
- EFS, IMRB, F-94010 Créteil, France
| | - Mélanie Gressette
- UMR-S 1180, INSERM, Université Paris-Sud, Université Paris-Saclay, F-92296 Châtenay-Malabry, France
| | - Audrey Solgadi
- UMS IPSIT, Université Paris-Saclay, F-92296 Châtenay-Malabry, France
| | - Florent Dumont
- UMS IPSIT, Université Paris-Saclay, F-92296 Châtenay-Malabry, France
| | - Julien Castel
- Université de Paris, BFA, UMR 8251, CNRS, F-75014 Paris, France
| | - Julien Ternacle
- Université Paris-Est Créteil, INSERM, IMRB, Team Derumeaux, F-94010 Creteil, France
| | - Jean Demarquoy
- Université Bourgogne Franche-Comté, AgroSup Dijon, PAM UMR A 02.102, F-21000 Dijon, France
| | - Alexandra Malgoyre
- Département Environnements Opérationnels, Unité de Physiologie des Exercices et Activités en Conditions Extrêmes, Institut de Recherche Biomédicale des Armées, F-91220 Brétigny-Sur-Orge, France
- LBEPS, Université Evry, IRBA, Université Paris-Saclay, F-91025 Evry, France
| | - Nathalie Koulmann
- Département Environnements Opérationnels, Unité de Physiologie des Exercices et Activités en Conditions Extrêmes, Institut de Recherche Biomédicale des Armées, F-91220 Brétigny-Sur-Orge, France
- LBEPS, Université Evry, IRBA, Université Paris-Saclay, F-91025 Evry, France
- École du Val de Grâce, Place Alphonse Laveran, F-75005 Paris, France
| | - Geneviève Derumeaux
- Université Paris-Est Créteil, INSERM, IMRB, Team Derumeaux, F-94010 Creteil, France
| | | | - Frédéric Joubert
- Laboratoire Jean Perrin, CNRS, Sorbonne Université, UMR 8237, Paris, F-75005, France
| | - Vladimir Veksler
- UMR-S 1180, INSERM, Université Paris-Sud, Université Paris-Saclay, F-92296 Châtenay-Malabry, France
| | - Serge Luquet
- Université de Paris, BFA, UMR 8251, CNRS, F-75014 Paris, France
| | - Frédéric Relaix
- Université Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France.
- EnvA, IMRB, F-94700 Maisons-Alfort, France
- EFS, IMRB, F-94010 Créteil, France
| | - Laurent Tiret
- Université Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France.
- EnvA, IMRB, F-94700 Maisons-Alfort, France
- EFS, IMRB, F-94010 Créteil, France
| | - Fanny Pilot-Storck
- Université Paris-Est Créteil, INSERM, IMRB, Team Relaix, F-94010 Créteil, France.
- EnvA, IMRB, F-94700 Maisons-Alfort, France
- EFS, IMRB, F-94010 Créteil, France
| |
Collapse
|
12
|
Kénanian G, Morvan C, Weckel A, Pathania A, Anba-Mondoloni J, Halpern D, Gaillard M, Solgadi A, Dupont L, Henry C, Poyart C, Fouet A, Lamberet G, Gloux K, Gruss A. Permissive Fatty Acid Incorporation Promotes Staphylococcal Adaptation to FASII Antibiotics in Host Environments. Cell Rep 2020; 29:3974-3982.e4. [PMID: 31851927 DOI: 10.1016/j.celrep.2019.11.071] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2019] [Revised: 10/01/2019] [Accepted: 11/15/2019] [Indexed: 02/08/2023] Open
Abstract
The essentiality of fatty acid synthesis (FASII) products in the human pathogen Staphylococcus aureus is the underlying rationale for FASII-targeted antimicrobial drug design. Reports of anti-FASII efficacy in animals support this choice. However, restricted test conditions used previously led us to investigate this postulate in a broader, host-relevant context. We report that S. aureus rapidly adapts to FASII antibiotics without FASII mutations when exposed to host environments. FASII antibiotic administration upon signs of infection, rather than just after inoculation as commonly practiced, fails to eliminate S. aureus in a septicemia model. In vitro, serum lowers S. aureus membrane stress, leading to a greater retention of the substrates required for environmental fatty acid (eFA) utilization: eFAs and the acyl carrier protein. In this condition, eFA occupies both phospholipid positions, regardless of anti-FASII selection. Our results identify S. aureus membrane plasticity in host environments as a main limitation for using FASII antibiotics in monotherapeutic treatments.
Collapse
Affiliation(s)
- Gérald Kénanian
- Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy en Josas, France
| | - Claire Morvan
- Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy en Josas, France
| | - Antonin Weckel
- Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, 75014 Paris, France
| | - Amit Pathania
- Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy en Josas, France
| | - Jamila Anba-Mondoloni
- Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy en Josas, France
| | - David Halpern
- Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy en Josas, France
| | - Marine Gaillard
- Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, 75014 Paris, France
| | - Audrey Solgadi
- SAMM, UMS IPSIT, Faculté de Pharmacie, Université Paris-Saclay, Chatenay-Malabry, France
| | - Laetitia Dupont
- Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy en Josas, France
| | - Céline Henry
- PAPPSO Platform, Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France
| | - Claire Poyart
- Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, 75014 Paris, France; Centre National de Référence des Streptocoques, Hôpitaux Universitaires Paris Centre Site Cochin, APHP, Paris, France
| | - Agnès Fouet
- Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, 75014 Paris, France
| | - Gilles Lamberet
- Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy en Josas, France
| | - Karine Gloux
- Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy en Josas, France
| | - Alexandra Gruss
- Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy en Josas, France.
| |
Collapse
|
13
|
Benrabah L, Kemel K, Twarog C, Huang N, Solgadi A, Laugel C, Faivre V. Lipid-based Janus nanoparticles for pharmaceutical and cosmetic applications: Kinetics and mechanisms of destabilization with time and temperature. Colloids Surf B Biointerfaces 2020; 195:111242. [PMID: 32652399 DOI: 10.1016/j.colsurfb.2020.111242] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Revised: 06/26/2020] [Accepted: 07/02/2020] [Indexed: 01/05/2023]
Abstract
The aim of this paper is to investigate the time and thermal stability of innovative multicompartmental nanoparticles. These particles, having a hydrophilic side and a hydrophobic side, belong to the family of Janus particles and are promising tools to carry active ingredients with opposite solubilities in a unique nanocarrier. The stability of nanoparticles obtained with mainly two types of polyoxylglycerides (Labrafil® M2125 CS and Labrafil® M1944 CS) has been investigated. The suspensions describe a two-step maturation/destabilization process with an Ostwald ripening phase followed by the coalescence of the particles. The effect of lipid composition and temperature on these steps has been investigated in deep as stability with temperature is a critical parameter to consider in order to envisage the development of any formulation for pharmaceutical or cosmetic uses. These nanoparticles were particularly stable at room temperature as their hydrodynamic diameter did not change significantly for 20 months. Contrarily, a strong dependency to temperature appears when storage temperature increases from 25 °C to 43 °C. Indeed, Labrafil® M1944 CS seemed to undergo a progressive destabilization where a significant increase of particles size is visible from 25 °C and phase separation occurred after 4 months at 32 °C. At the opposite, Labrafil® M2125 CS remained stable until 36 °C and reached a threshold temperature between 32 °C and 36 °C after which Labrafil® M2125 CS underwent a consequent increase of particles size at the longer time, i.e. after 6 months. Moreover, Labrafil® M2125 CS formulation was stable at least 3 months at 43 °C.
Collapse
Affiliation(s)
- L Benrabah
- Institut Galien Paris-Sud, Université Paris-Saclay, Labex LERMIT, 92296, Châtenay-Malabry, France
| | - K Kemel
- Lip(Sys)² Chimie Analytique Pharmaceutique, EA7357 Université Paris-Saclay, 92296, Châtenay-Malabry, France
| | - C Twarog
- Institut Galien Paris-Sud, Université Paris-Saclay, Labex LERMIT, 92296, Châtenay-Malabry, France
| | - N Huang
- Institut Galien Paris-Sud, Université Paris-Saclay, Labex LERMIT, 92296, Châtenay-Malabry, France
| | - A Solgadi
- Service d'Analyse des Médicaments et Métabolites (SAMM), SFR-UMS IPSIT, Université Paris-Saclay, 92296, Châtenay-Malabry, France
| | - C Laugel
- Lip(Sys)² Chimie Analytique Pharmaceutique, EA7357 Université Paris-Saclay, 92296, Châtenay-Malabry, France
| | - V Faivre
- Institut Galien Paris-Sud, Université Paris-Saclay, Labex LERMIT, 92296, Châtenay-Malabry, France.
| |
Collapse
|
14
|
Wang Z, Landy D, Sizun C, Cézard C, Solgadi A, Przybylski C, de Chaisemartin L, Herfindal L, Barratt G, Legrand FX. Cyclodextrin complexation studies as the first step for repurposing of chlorpromazine. Int J Pharm 2020; 584:119391. [PMID: 32376444 DOI: 10.1016/j.ijpharm.2020.119391] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2020] [Revised: 04/27/2020] [Accepted: 04/28/2020] [Indexed: 01/07/2023]
Abstract
The antipsychotic drug chlorpromazine (CPZ) has potential for the treatment of acute myeloid leukemia, if central nervous system side-effects resulting from its passage through the blood-brain barrier can be prevented. A robust drug delivery system for repurposed CPZ would be drug-in-cyclodextrin-in-liposome that would redirect the drug away from the brain while avoiding premature release in the circulation. As a first step, CPZ complexation with cyclodextrin (CD) has been studied. The stoichiometry, binding constant, enthalpy, and entropy of complex formation between CPZ and a panel of CDs was investigated by isothermal titration calorimetry (ITC). All the tested CDs were able to include CPZ, in the form of 1:1, 1:2 or a mixture of 1:1 and 1:2 complexes. In particular, a substituted γ-CD, sugammadex (the octasodium salt of octakis(6-deoxy-6-S-(2-carboxyethyl)-6-thio)cyclomaltooctaose), formed exclusively 1:2 complexes with an extremely high association constant of 6.37 × 109 M-2. Complexes were further characterized by heat capacity changes, one- and two-dimensional (ROESY) nuclear magnetic resonance (NMR) spectroscopy and molecular dynamics simulations. Finally, protection of CPZ against photodegradation by CDs was assessed. This was accelerated rather than reduced by complexation with CD. Altogether these results provide a molecular basis for the use of CD in delayed release formulations for CPZ.
Collapse
Affiliation(s)
- Zhiqiang Wang
- Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 92290 Châtenay-Malabry, France
| | - David Landy
- Unité de Chimie Environnementale et Interactions sur le Vivant (UCEIV, EA 4492), SFR Condorcet FR CNRS 3417, Université du Littoral Côte d'Opale, 59140 Dunkerque, France
| | - Christina Sizun
- Université Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, UPR 2301, 91198 Gif-sur-Yvette, France
| | - Christine Cézard
- Laboratoire de Glycochimie, des Antimicrobiens et des Agroressources, CNRS UMR 7378, Université de Picardie Jules Verne, 80000 Amiens, France
| | - Audrey Solgadi
- Université Paris-Saclay, Inserm, CNRS, Ingénierie et Plateformes au Service de l'Innovation Thérapeutique, 92290 Châtenay-Malabry, France
| | - Cédric Przybylski
- Institut Parisien de Chimie Moléculaire, CNRS UMR 8232, Sorbonne Université, 75005 Paris, France
| | - Luc de Chaisemartin
- Service d'Immunologie, Hôpital Bichat-Claude-Bernard, Assistance Publique-Hôpitaux de Paris, 75018 Paris, France; Université Paris-Saclay, Inserm, Inflammation, Microbiome and Immunosurveillance, 92290 Châtenay-Malabry, France
| | - Lars Herfindal
- Department of Clinical Science, University of Bergen, Jonas Lies Vei 87, 5009 Bergen, Norway
| | - Gillian Barratt
- Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 92290 Châtenay-Malabry, France
| | - François-Xavier Legrand
- Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 92290 Châtenay-Malabry, France.
| |
Collapse
|
15
|
Assi A, Bakar J, Libong D, Sarkees E, Solgadi A, Baillet-Guffroy A, Michael-Jubeli R, Tfayli A. Comprehensive characterization and simultaneous analysis of overall lipids in reconstructed human epidermis using NPLC/HR-MSn: 1-O-E (EO) Cer, a new ceramide subclass. Anal Bioanal Chem 2019; 412:777-793. [DOI: 10.1007/s00216-019-02301-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2019] [Revised: 11/05/2019] [Accepted: 11/22/2019] [Indexed: 10/25/2022]
|
16
|
Grimbert L, Sanz MN, Rucker-Martin C, Novotova M, Gressette M, Gomez S, Solgadi A, Dumont F, Ventura-Clapier R, Veksler V, Piquereau J, Garnier A. P6276Impact of the cardiac specific deletion of AMPKalpha2 on the contractile and metabolic phenotype of the heart in male and female mice. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Mitochondrial dysfunction plays a major role in the Heart Failure (HF) pathophysiology.The AMP activated protein kinase (AMPK) is activated by a high AMP-ADP/ATP ratio and regulates a number of metabolic pathways. Many studies have highlighted a protective role of AMPK in HF, but its relevance to cardiac tissue, its metabolic part and its sex specificity are not well established.
Purpose
Then, the aim of this study is to determine the role of AMPK in the healthy and failing heart in male and female mice.
Methods
We developed and validated a mouse strain with an adult-inducible cardiac-specific deletion of AMPKα2, the major cardiac isoform, using the Cre-Lox system (40mg/kg tamoxifen injection on two consecutive days at adult age). At four months after the deletion, cardiac contractility, morphology and metabolism were studied in control and KO mice from both sexes.
Results
We observed only in male KO mice a decrease of left ventricular ejection fraction (−10%), an increase of the total fibrosis (+64%) and defects in mitochondrial structures. Male KO mice also showed a reduced (−28%) mitochondrial respiration via complex I associated with a different cardiolipin species distribution.
Conclusion
Our results reveal in adult healthy hearts, a sex-specificity in the effects of AMPKα2 deletion, leading to impaired contractile function related to metabolic and non-metabolic alterations only in male mice.
Collapse
Affiliation(s)
- L Grimbert
- Paris-Sud University, Paris-Saclay University, UMR-S 1180, Chatenay-Malabry, France
| | - M N Sanz
- Paris-Sud University, Paris-Saclay University, UMR-S 1180, Chatenay-Malabry, France
| | - C Rucker-Martin
- Surgical Centre Marie Lannelongue, U999, Le Plessis Robinson, France
| | - M Novotova
- Slovak Academy of Sciences, Institute of Molecular Physiology and Genetics, Bratislava, Slovakia
| | - M Gressette
- Paris-Sud University, Paris-Saclay University, UMR-S 1180, Chatenay-Malabry, France
| | - S Gomez
- Paris-Sud University, Paris-Saclay University, UMR-S 1180, Chatenay-Malabry, France
| | - A Solgadi
- Paris-Sud University, Paris-Saclay University, UMR-S 1180, Chatenay-Malabry, France
| | - F Dumont
- Paris-Sud University, Paris-Saclay University, UMR-S 1180, Chatenay-Malabry, France
| | - R Ventura-Clapier
- Paris-Sud University, Paris-Saclay University, UMR-S 1180, Chatenay-Malabry, France
| | - V Veksler
- Paris-Sud University, Paris-Saclay University, UMR-S 1180, Chatenay-Malabry, France
| | - J Piquereau
- Paris-Sud University, Paris-Saclay University, UMR-S 1180, Chatenay-Malabry, France
| | - A Garnier
- Paris-Sud University, Paris-Saclay University, UMR-S 1180, Chatenay-Malabry, France
| |
Collapse
|
17
|
Kanonenberg K, Royes J, Kedrov A, Poschmann G, Angius F, Solgadi A, Spitz O, Kleinschrodt D, Stühler K, Miroux B, Schmitt L. Shaping the lipid composition of bacterial membranes for membrane protein production. Microb Cell Fact 2019; 18:131. [PMID: 31400768 PMCID: PMC6689329 DOI: 10.1186/s12934-019-1182-1] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2019] [Accepted: 07/30/2019] [Indexed: 12/29/2022] Open
Abstract
Background The overexpression and purification of membrane proteins is a bottleneck in biotechnology and structural biology. E. coli remains the host of choice for membrane protein production. To date, most of the efforts have focused on genetically tuning of expression systems and shaping membrane composition to improve membrane protein production remained largely unexplored. Results In E. coli C41(DE3) strain, we deleted two transporters involved in fatty acid metabolism (OmpF and AcrB), which are also recalcitrant contaminants crystallizing even at low concentration. Engineered expression hosts presented an enhanced fitness and improved folding of target membrane proteins, which correlated with an altered membrane fluidity. We demonstrated the scope of this approach by overproducing several membrane proteins (4 different ABC transporters, YidC and SecYEG). Conclusions In summary, E. coli membrane engineering unprecedentedly increases the quality and yield of membrane protein preparations. This strategy opens a new field for membrane protein production, complementary to gene expression tuning. Electronic supplementary material The online version of this article (10.1186/s12934-019-1182-1) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Kerstin Kanonenberg
- Institute of Biochemistry, Heinrich-Heine-University Duesseldorf, Universitaetsstr. 1, 40225, Duesseldorf, Germany.,CNRS, UMR5086 "Molecular Microbiology and Structural Biochemistry", Université de Lyon, 7 Passage du vercors, 69007, Lyon, France
| | - Jorge Royes
- Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, UMR7099, CNRS, IBPC, Université Paris Diderot, Sorbonne Paris Cité, 13 rue Pierre et Marie Curie, 75005, Paris, France
| | - Alexej Kedrov
- Institute of Biochemistry, Heinrich-Heine-University Duesseldorf, Universitaetsstr. 1, 40225, Duesseldorf, Germany
| | - Gereon Poschmann
- Molecular Proteomics Laboratory, Biologisch Medizinisches Forschungszentrum (BMFZ), Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
| | - Federica Angius
- Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, UMR7099, CNRS, IBPC, Université Paris Diderot, Sorbonne Paris Cité, 13 rue Pierre et Marie Curie, 75005, Paris, France.,Department of Microbiology, Institute for Water and Wetland Research, Heyendaalseweg 135, 6525, Nijmegen, The Netherlands
| | - Audrey Solgadi
- Institut Paris Saclay d'Innovation Thérapeutique, INSERM, CNRS, - Plateforme SAMM, Université Paris-Saclay, Châtenay-Malabry, France
| | - Olivia Spitz
- Institute of Biochemistry, Heinrich-Heine-University Duesseldorf, Universitaetsstr. 1, 40225, Duesseldorf, Germany
| | - Diana Kleinschrodt
- Institute of Biochemistry, Heinrich-Heine-University Duesseldorf, Universitaetsstr. 1, 40225, Duesseldorf, Germany
| | - Kai Stühler
- Molecular Proteomics Laboratory, Biologisch Medizinisches Forschungszentrum (BMFZ), Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
| | - Bruno Miroux
- Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, UMR7099, CNRS, IBPC, Université Paris Diderot, Sorbonne Paris Cité, 13 rue Pierre et Marie Curie, 75005, Paris, France.
| | - Lutz Schmitt
- Institute of Biochemistry, Heinrich-Heine-University Duesseldorf, Universitaetsstr. 1, 40225, Duesseldorf, Germany.
| |
Collapse
|
18
|
Grimbert L, Sanz M, Rucker-Martin C, Novotova M, Gressette M, Gomez S, Solgadi A, Dumont F, Ventura-Clapier R, Veksler V, Piquereau J, Garnier A. Metabolic and non-metabolic effects of cardiac-specific and inducible deletion of the AMPKalpha2 in female and male mice. Archives of Cardiovascular Diseases Supplements 2019. [DOI: 10.1016/j.acvdsp.2019.02.110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
19
|
Secrétan PH, Karoui M, Sadou Yayé H, Levi Y, Tortolano L, Solgadi A, Yagoubi N, Do B. Imatinib: Major photocatalytic degradation pathways in aqueous media and the relative toxicity of its transformation products. Sci Total Environ 2019; 655:547-556. [PMID: 30476834 DOI: 10.1016/j.scitotenv.2018.11.270] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/01/2018] [Revised: 11/13/2018] [Accepted: 11/18/2018] [Indexed: 06/09/2023]
Abstract
Imatinib (IMA) is a highly potent tyrosine kinase inhibitor used as first-line anti-cancer drug in the treatment of chronic myeloid leukemia. Due to its universal mechanism of action, IMA also has endocrine and mutagenic disrupting effects in vivo and in vitro, which raises the question of its environmental impact. However, to date, very little information is available on its environmental fate and the potential role of its transformation products (TPs) on aquatic organisms. Given the IMA resistance to hydrolysis and direct photolysis according to the literature, we sought to generate TPs through oxidative and radical conditions using the AOPs pathway. Thus, the reactivity of the cytotoxic drug IMA in water in the presence of OH and h+ was investigated for the first time in the present work. In this regard, a non-targeted screening approach was applied in order to reveal its potential TPs. The tentative structural elucidation of the detected TPs was performed by LC-HRMSn. The proposed approach allowed detecting a total of twelve TPs, among which eleven are being described for the first time in this work. Although the structures of these TPs could not be positively confirmed due to lack of standards, their chemical formulas and product ions can be added to databases, which will allow their screening in future monitoring studies. Using the quantitative structure-activity relationship (QSAR) approach and rule-based software, we have shown that the detected TPs possess, like their parent molecule, comparable acute toxicity as well as mutagenic and estrogenic potential. In addition to the in silico studies, we also found that the samples obtained at different exposure times to oxidative conditions, including those where IMA is no longer detected, retained toxicity in vitro. Such results suggest further studies are needed to increase our knowledge of the impact of imatinib on the environment.
Collapse
Affiliation(s)
- P H Secrétan
- University of Paris-Sud, Department of Pharmacy, Laboratory "Matériaux et Santé" EA 401, 5 rue Jean Baptiste Clément, 92296 Châtenay-Malabry, France; Assistance Publique-Hôpitaux de Paris, Hôpital Necker, Department of Pharmacy, 149 Rue de Sèvres, 75015 Paris, France.
| | - M Karoui
- University of Paris-Sud, Department of Pharmacy, Laboratory "Matériaux et Santé" EA 401, 5 rue Jean Baptiste Clément, 92296 Châtenay-Malabry, France
| | - H Sadou Yayé
- University of Paris-Sud, Department of Pharmacy, Laboratory "Matériaux et Santé" EA 401, 5 rue Jean Baptiste Clément, 92296 Châtenay-Malabry, France; Assistance Publique-Hôpitaux de Paris, Groupe Pitié-Salpétrière, Department of Pharmacy, 47-83 Boulevard de l'Hôpital, 75013, Paris
| | - Y Levi
- University of Paris-Sud, Faculté de Pharmacie, UMR 8079, CNRS, AgroParisTech, Paris, France
| | - L Tortolano
- University of Paris-Sud, Department of Pharmacy, Laboratory "Matériaux et Santé" EA 401, 5 rue Jean Baptiste Clément, 92296 Châtenay-Malabry, France; Assistance Publique-Hôpitaux de Paris, Groupe hospitalier Henri Mondor, Department of Pharmacy, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France
| | - A Solgadi
- University of Paris-Sud, Faculté de Pharmacie, Service d'Analyse des Médicaments et Métabolites, Institut d'Innovation Thérapeutique, 5 rue Jean Baptiste Clément, 92296 Chatenay-Malabry, France
| | - N Yagoubi
- University of Paris-Sud, Department of Pharmacy, Laboratory "Matériaux et Santé" EA 401, 5 rue Jean Baptiste Clément, 92296 Châtenay-Malabry, France
| | - B Do
- University of Paris-Sud, Department of Pharmacy, Laboratory "Matériaux et Santé" EA 401, 5 rue Jean Baptiste Clément, 92296 Châtenay-Malabry, France; Assistance Publique-Hôpitaux de Paris, Groupe hospitalier Henri Mondor, Department of Pharmacy, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France
| |
Collapse
|
20
|
Popa I, Watson AL, Solgadi A, Butowski C, Allaway D, Portoukalian J. Linoleate-enriched diet increases both linoleic acid esterified to omega hydroxy very long chain fatty acids and free ceramides of canine stratum corneum without effect on protein-bound ceramides and skin barrier function. Arch Dermatol Res 2018; 310:579-589. [PMID: 29995261 PMCID: PMC6096565 DOI: 10.1007/s00403-018-1845-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2018] [Revised: 06/08/2018] [Accepted: 06/14/2018] [Indexed: 12/27/2022]
Abstract
Few studies have investigated the influence of increased amounts of dietary linoleic acid on the epidermal lipid biochemistry and TEWL in healthy subject. The influence of dietary linoleic acid on canine stratum corneum (SC) lipids was studied by feeding two groups of five dogs differential amounts of linoleic acid (LA) for three months. SC was harvested by tape stripping and lipids were analyzed by thin-layer chromatography and mass spectrometry. The dogs that were fed the higher concentration of LA showed high increases in the contents of both linoleic acid and free ceramides in the SC, whereas the protein-bound ceramide content was unchanged. Acylacids that represent the esterified form of linoleic acid in omega hydroxy very long chain fatty acids (ω-OH VLCFA) accounted for most of the elevation of LA, whereas the concentration of the free form was not significantly changed. Corroborating the absence of change in the protein-bound ceramides content of healthy dogs SC, TEWL was nearly unaffected by the linoleic acid-enriched diet.
Collapse
Affiliation(s)
- Iuliana Popa
- Faculty of Pharmacy, University Paris-Sud, Chatenay-Malabry, France.
| | | | - Audrey Solgadi
- UMS 3679 CNRS, Faculty of Pharmacy, University Paris-Sud, Chatenay-Malabry, France
| | | | | | - Jacques Portoukalian
- LBTM1 "Fundamental, clinical and therapeutic aspects of the skin barrier function", University of Lyon-1, Lyon, France
| |
Collapse
|
21
|
Secrétan PH, Karoui M, Levi Y, Sadou Yayé H, Tortolano L, Solgadi A, Yagoubi N, Do B. Pemetrexed degradation by photocatalytic process: Kinetics, identification of transformation products and estimation of toxicity. Sci Total Environ 2018; 624:1082-1094. [PMID: 29625523 DOI: 10.1016/j.scitotenv.2017.12.182] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/12/2017] [Revised: 12/16/2017] [Accepted: 12/17/2017] [Indexed: 06/08/2023]
Abstract
This study employed a UV-A/visible/TiO2 system to investigate the degradation of pemetrexed, an antifolate agent used in chemotherapy. The laboratory-scale method employed a photostability chamber that could be used to study multiple samples. Reversed-phase HPLC coupled with high-resolution ESI-LTQ-Orbitrap mass spectrometry was used to determine the transformation products (TPs) of PEME. Based on the identified TPs and existing chemical knowledge, the mechanism of degradation of the target compound was proposed. Concentrations were monitored as a function of time, and the degradation kinetics were compared. The structures of seven TPs, four of which have not been described to date, were proposed. Most of the TPs stemmed from OH radical additions to the dihydropyrrole moiety and oxidative decarboxylation of the glutamate residue. Based on the elucidated structures, a computational toxicity assessment was performed, showing that the TPs with higher log D values than the parent compound are more toxic than the PEME itself. To support these findings, the toxicities of irradiated samples on Vibrio fischeri were monitored over time. The experimental results corresponded well with the results of previous computational studies.
Collapse
Affiliation(s)
- Philippe-Henri Secrétan
- University of Paris-Sud, Department of Pharmacy, Laboratory "Matériaux et Santé" EA 401, 5 rue Jean Baptiste Clément, 92296 Châtenay-Malabry, France; Assistance Publique-Hôpitaux de Paris, Hôpital Necker, Department of Pharmacy, 149 Rue de Sèvres, 75015 Paris, France.
| | - Maher Karoui
- University of Paris-Sud, Department of Pharmacy, Laboratory "Matériaux et Santé" EA 401, 5 rue Jean Baptiste Clément, 92296 Châtenay-Malabry, France; Assistance Publique-Hôpitaux de Paris, Groupe hospitalier Henri Mondor, Department of Pharmacy, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France
| | - Yves Levi
- University of Paris-Sud, Faculté de Pharmacie, UMR 8079, CNRS, AgroParisTech, Paris, France
| | - Hassane Sadou Yayé
- University of Paris-Sud, Department of Pharmacy, Laboratory "Matériaux et Santé" EA 401, 5 rue Jean Baptiste Clément, 92296 Châtenay-Malabry, France
| | - Lionel Tortolano
- University of Paris-Sud, Department of Pharmacy, Laboratory "Matériaux et Santé" EA 401, 5 rue Jean Baptiste Clément, 92296 Châtenay-Malabry, France; Assistance Publique-Hôpitaux de Paris, Groupe hospitalier Henri Mondor, Department of Pharmacy, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France
| | - Audrey Solgadi
- University of Paris-Sud, Faculté de Pharmacie, Service d'Analyse des Médicaments et Métabolites, Institut d'Innovation Thérapeutique, 5 rue Jean Baptiste Clément, 92296 Chatenay-Malabry, France
| | - Najet Yagoubi
- University of Paris-Sud, Department of Pharmacy, Laboratory "Matériaux et Santé" EA 401, 5 rue Jean Baptiste Clément, 92296 Châtenay-Malabry, France
| | - Bernard Do
- University of Paris-Sud, Department of Pharmacy, Laboratory "Matériaux et Santé" EA 401, 5 rue Jean Baptiste Clément, 92296 Châtenay-Malabry, France; Assistance Publique-Hôpitaux de Paris, Groupe hospitalier Henri Mondor, Department of Pharmacy, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France
| |
Collapse
|
22
|
Defaix C, Solgadi A, Pham TH, Gardier AM, Chaminade P, Tritschler L. Rapid analysis of glutamate, glutamine and GABA in mice frontal cortex microdialysis samples using HPLC coupled to electrospray tandem mass spectrometry. J Pharm Biomed Anal 2018; 152:31-38. [DOI: 10.1016/j.jpba.2018.01.039] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2017] [Revised: 01/17/2018] [Accepted: 01/18/2018] [Indexed: 12/17/2022]
|
23
|
Abreu S, Solgadi A, Chaminade P. Optimization of normal phase chromatographic conditions for lipid analysis and comparison of associated detection techniques. J Chromatogr A 2017; 1514:54-71. [PMID: 28774713 DOI: 10.1016/j.chroma.2017.07.063] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2016] [Revised: 07/07/2017] [Accepted: 07/18/2017] [Indexed: 02/02/2023]
Abstract
One important challenge in lipid class analysis is to develop a method suitable or, at least adaptable, for a vast diversity of samples. In the current study, an improved normal-phase liquid chromatography (NPLC) method allowed analyzing the lipid classes present in mammalian, vegetable as well as microorganism (yeast and bacteria) lipid samples. The method effectively separated 30 lipid classes or subclasses with a special focus on medium polarity lipids. The separation was carried out with bare silica stationary phase and was coupled to evaporative light scattering detection (ELSD), charged aerosol detection (Corona-CAD®) and mass spectrometry. Solutions are provided to circumvent technical issues (such as pumping solvents of low viscosity, solvent purity, rinsing step). The influence of mobile phase composition and addition of ionic modifiers on the chromatographic behavior of particular lipid classes is documented. A comparison between ELSD and Corona-CAD® confirmed the interest of this later detector for samples with a wide range of concentration of different lipids. Three common atmospheric pressure ionization interfaces were used for coupling the NPLC separation to a LTQ Velos Pro® mass spectrometer. The comparison of the chromatographic profiles showed that atmospheric pressure chemical ionization (APCI) and atmospheric pressure photoionization (APPI) are both suitable to detect the different lipid classes whereas APPI allows a better sensitivity for lipids at low-concentration.
Collapse
Affiliation(s)
- Sonia Abreu
- Lip(Sys)2, Chimie Analytique Pharmaceutique (FKA EA4041 Groupe de Chimie Analytique de Paris-Sud), Univ. Paris-Sud, Université Paris-Saclay, F-92290 Châtenay-Malabry, France
| | - Audrey Solgadi
- SAMM, UMS IPSIT, Université Paris Sud, Université Paris-Saclay, Chatenay-Malabry, France
| | - Pierre Chaminade
- Lip(Sys)2, Chimie Analytique Pharmaceutique (FKA EA4041 Groupe de Chimie Analytique de Paris-Sud), Univ. Paris-Sud, Université Paris-Saclay, F-92290 Châtenay-Malabry, France.
| |
Collapse
|
24
|
Sayet G, Fournier N, Caudron E, Tfaili S, Solgadi A, Paul JL, Chaminade P. Lipidomic study of the impact of eicosapentaenoic acid (EPA) on abca1-mediated cholesterol efflux from human macrophages. Atherosclerosis 2017. [DOI: 10.1016/j.atherosclerosis.2017.06.726] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
25
|
Fournier N, Sayet G, Vedie B, Nowak M, Allaoui F, Solgadi A, Caudron E, Chaminade P, Benoist JF, Paul JL. Eicosapentaenoic acid membrane incorporation impairs cholesterol efflux from cholesterol-loaded human macrophages by reducing the cholesteryl ester mobilization from lipid droplets. Biochim Biophys Acta Mol Cell Biol Lipids 2017; 1862:1079-1091. [PMID: 28739279 DOI: 10.1016/j.bbalip.2017.07.011] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2017] [Revised: 07/18/2017] [Accepted: 07/20/2017] [Indexed: 12/26/2022]
Abstract
A diet containing a high n-3/n-6 polyunsaturated fatty acids (PUFA) ratio has cardioprotective properties. PUFAs incorporation into membranes influences the function of membrane proteins. We investigated the impact of the membrane incorporation of PUFAs, especially eicosapentaenoic acid (EPA) (C20:5 n-3), on the anti-atherogenic cholesterol efflux pathways. We used cholesteryl esters (CE)-loaded human monocyte-derived macrophages (HMDM) to mimic foam cells exposed to the FAs for a long period of time to ensure their incorporation into cellular membranes. Phospholipid fraction of EPA cells exhibited high levels of EPA and its elongation product docosapentaenoic acid (DPA) (C22:5 n-3), which was associated with a decreased level of arachidonic acid (AA) (C20:4 n-6). EPA 70μM reduced ABCA1-mediated cholesterol efflux to apolipoprotein (apo) AI by 30% without any alteration in ABCA1 expression. The other tested PUFAs, DPA, docosahexaenoic acid (DHA) (C22:6 n-3), and AA, were also able to reduce ABCA1 functionality while the monounsaturated oleic FA slightly decreased efflux and the saturated palmitic FA had no impact. Moreover, EPA also reduced cholesterol efflux to HDL mediated by the Cla-1 and ABCG1 pathways. EPA incorporation did not hinder efflux in free cholesterol-loaded HMDM and did not promote esterification of cholesterol. Conversely, EPA reduced the neutral hydrolysis of cytoplasmic CE by 24%. The reduced CE hydrolysis was likely attributed to the increase in cellular TG contents and/or the decrease in apo E secretion after EPA treatment. In conclusion, EPA membrane incorporation reduces cholesterol efflux in human foam cells by reducing the cholesteryl ester mobilization from lipid droplets.
Collapse
Affiliation(s)
- Natalie Fournier
- Univ Paris Sud-Paris Saclay, EA 7357, Lip(Sys)(2), Athérosclérose: homéostasie et trafic du cholestérol des macrophages (FKA EA 4529), UFR de Pharmacie, 92296 Châtenay-Malabry, France; AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpital Européen Georges Pompidou, Laboratoire de Biochimie, 75015 Paris, France.
| | - Guillaume Sayet
- Univ Paris Sud-Paris Saclay, EA 7357, Lip(Sys)(2), Chimie Analytique Pharmaceutique (FKA EA 4041), UFR de Pharmacie, 92296 Châtenay-Malabry, France
| | - Benoît Vedie
- AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpital Européen Georges Pompidou, Laboratoire de Biochimie, 75015 Paris, France
| | - Maxime Nowak
- Univ Paris Sud-Paris Saclay, EA 7357, Lip(Sys)(2), Athérosclérose: homéostasie et trafic du cholestérol des macrophages (FKA EA 4529), UFR de Pharmacie, 92296 Châtenay-Malabry, France
| | - Fatima Allaoui
- Univ Paris Sud-Paris Saclay, EA 7357, Lip(Sys)(2), Athérosclérose: homéostasie et trafic du cholestérol des macrophages (FKA EA 4529), UFR de Pharmacie, 92296 Châtenay-Malabry, France
| | - Audrey Solgadi
- Univ Paris Sud-Paris Saclay, SFR IPSIT (Institut Paris-Saclay d'Innovation Thérapeutique), UMS IPSIT Service d'Analyse des Médicaments et Métabolites, 92296 Châtenay-Malabry, France
| | - Eric Caudron
- Univ Paris Sud-Paris Saclay, EA 7357, Lip(Sys)(2), Chimie Analytique Pharmaceutique (FKA EA 4041), UFR de Pharmacie, 92296 Châtenay-Malabry, France
| | - Pierre Chaminade
- Univ Paris Sud-Paris Saclay, EA 7357, Lip(Sys)(2), Chimie Analytique Pharmaceutique (FKA EA 4041), UFR de Pharmacie, 92296 Châtenay-Malabry, France
| | - Jean-François Benoist
- AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpital Robert Debré, Laboratoire de Biochimie hormonale, 75019 Paris, France
| | - Jean-Louis Paul
- Univ Paris Sud-Paris Saclay, EA 7357, Lip(Sys)(2), Athérosclérose: homéostasie et trafic du cholestérol des macrophages (FKA EA 4529), UFR de Pharmacie, 92296 Châtenay-Malabry, France; AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpital Européen Georges Pompidou, Laboratoire de Biochimie, 75015 Paris, France
| |
Collapse
|
26
|
Carranza G, Angius F, Ilioaia O, Solgadi A, Miroux B, Arechaga I. Cardiolipin plays an essential role in the formation of intracellular membranes in Escherichia coli. Biochim Biophys Acta Biomembr 2017; 1859:1124-1132. [PMID: 28284722 DOI: 10.1016/j.bbamem.2017.03.006] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/15/2016] [Revised: 02/22/2017] [Accepted: 03/07/2017] [Indexed: 02/07/2023]
Abstract
Mitochondria, chloroplasts and photosynthetic bacteria are characterized by the presence of complex and intricate membrane systems. In contrast, non-photosynthetic bacteria lack membrane structures within their cytoplasm. However, large scale over-production of some membrane proteins, such as the fumarate reductase, the mannitol permease MtlA, the glycerol acyl transferase PlsB, the chemotaxis receptor Tsr or the ATP synthase subunit b, can induce the proliferation of intra cellular membranes (ICMs) in the cytoplasm of Escherichia coli. These ICMs are particularly rich in cardiolipin (CL). Here, we have studied the effect of CL in the generation of these membranous structures. We have deleted the three genes (clsA, clsB and clsC) responsible of CL biosynthesis in E. coli and analysed the effect of these mutations by fluorescent and electron microscopy and by lipid mass spectrometry. We have found that CL is essential in the formation of non-lamellar structures in the cytoplasm of E. coli cells. These results could help to understand the structuration of membranes in E. coli and other membrane organelles, such as mitochondria and ER.
Collapse
Affiliation(s)
- Gerardo Carranza
- Departamento de Biología Molecular and Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Universidad de Cantabria - CSIC - SODERCAN, Santander, Spain
| | - Federica Angius
- Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, Institut de Biologie Physico-Chimique, CNRS, Univ Paris Diderot, Sorbonne Paris Cité, PSL Research University, Paris, France
| | - Oana Ilioaia
- Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, Institut de Biologie Physico-Chimique, CNRS, Univ Paris Diderot, Sorbonne Paris Cité, PSL Research University, Paris, France
| | - Audrey Solgadi
- Université Paris-Saclay, Institut Paris Saclay d'Innovation Thérapeutique, INSERM, CNRS, - Plateforme SAMM - CHATENAY-MALABRY, France
| | - Bruno Miroux
- Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, Institut de Biologie Physico-Chimique, CNRS, Univ Paris Diderot, Sorbonne Paris Cité, PSL Research University, Paris, France.
| | - Ignacio Arechaga
- Departamento de Biología Molecular and Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Universidad de Cantabria - CSIC - SODERCAN, Santander, Spain.
| |
Collapse
|
27
|
Essaid D, Rosilio V, Daghildjian K, Solgadi A, Vergnaud J, Kasselouri A, Chaminade P. Artificial plasma membrane models based on lipidomic profiling. Biochim Biophys Acta 2016; 1858:2725-2736. [PMID: 27457703 DOI: 10.1016/j.bbamem.2016.07.010] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/16/2016] [Revised: 06/18/2016] [Accepted: 07/21/2016] [Indexed: 12/27/2022]
Abstract
Phospholipid monolayers are often described as membrane models for analyzing drug-lipid interactions. In many works, a single phosphatidylcholine is chosen, sometimes with one or two additional components. Drug penetration is studied at 30mN/m, a surface pressure considered as corresponding to the pressure in bilayers, independently of the density of lipid molecular packing. In this work, we have extracted, identified, and quantified the major lipids constituting the lipidome of plasma and mitochondrial membranes of retinoblastoma (Y79) and retinal pigment epithelium cells (ARPE-19), using liquid chromatography coupled to high-resolution mass spectrometry (LC-MS/MS). The results obtained from this lipidomic analysis were used in an attempt to build an artificial lipid monolayer with a composition mimicking that of the plasma membrane of Y79 cells, better than a single phospholipid. The variety and number of lipid classes and species in cell extracts monolayers exceeding by far those of the phospholipids chosen to mimic them, the π-A isotherms of model monolayers differed from those of lipid extracts in shape and apparent packing density. We propose a model monolayer based on the most abundant species identified in the extracts, with a surface compressional modulus at 30mN/m close to the one of the lipid extracts.
Collapse
Affiliation(s)
- Donia Essaid
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France; Lip(Sys)(2), Chimie Analytique Pharmaceutique (FKA EA4041 Groupe de Chimie Analytique de Paris-Sud), Univ Paris-Sud, Université Paris-Saclay, F-92290 Châtenay-Malabry, France
| | - Véronique Rosilio
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France.
| | - Katia Daghildjian
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France
| | - Audrey Solgadi
- Institut Paris-Saclay d'Innovation Thérapeutique, UMS IPSIT SAMM, Châtenay-Malabry, France
| | - Juliette Vergnaud
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France
| | - Athena Kasselouri
- Lip(Sys)(2), Chimie Analytique Pharmaceutique (FKA EA4041 Groupe de Chimie Analytique de Paris-Sud), Univ Paris-Sud, Université Paris-Saclay, F-92290 Châtenay-Malabry, France
| | - Pierre Chaminade
- Lip(Sys)(2), Chimie Analytique Pharmaceutique (FKA EA4041 Groupe de Chimie Analytique de Paris-Sud), Univ Paris-Sud, Université Paris-Saclay, F-92290 Châtenay-Malabry, France
| |
Collapse
|
28
|
Buré C, Solgadi A, Yen-Nicolaÿ S, Bardeau T, Libong D, Abreu S, Chaminade P, Subra-Paternault P, Cansell M. Electrospray mass spectrometry as a tool to characterize phospholipid composition of plant cakes. EUR J LIPID SCI TECH 2016. [DOI: 10.1002/ejlt.201500345] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- Corinne Buré
- Centre de Génomique Fonctionnelle; CBMN, UMR 5248 CNRS, INP; University of Bordeaux; Bordeaux France
| | - Audrey Solgadi
- Université Paris Sud, SAMM, UMS IPSIT; Chatenay-Malabry France
| | | | - Tiphaine Bardeau
- University of Bordeaux, CBMN, UMR 5248; Pessac France
- CNRS, CBMN, UMR 5248; Pessac France
- Bordeaux INP, CBMN, UMR 5248; Pessac France
| | - Danielle Libong
- Université Paris Sud, SAMM, UMS IPSIT; Chatenay-Malabry France
- Université Paris Sud, LipSys; Chatenay-Malabry France
| | - Sonia Abreu
- Université Paris Sud, LipSys; Chatenay-Malabry France
| | - Pierre Chaminade
- Université Paris Sud, SAMM, UMS IPSIT; Chatenay-Malabry France
- Université Paris Sud, LipSys; Chatenay-Malabry France
| | | | - Maud Cansell
- University of Bordeaux, CBMN, UMR 5248; Pessac France
- CNRS, CBMN, UMR 5248; Pessac France
- Bordeaux INP, CBMN, UMR 5248; Pessac France
| |
Collapse
|
29
|
Henriet T, Secrétan PH, Amrani F, Sadou-Yayé H, Bernard M, Solgadi A, Yagoubi N, Do B. Phototransformation patterns of the antiplatelet drug tirofiban in aqueous solution, relevant to drug delivery and storage. NEW J CHEM 2016. [DOI: 10.1039/c5nj01826a] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Tirofiban in aqueous solution mostly photodegrades through photosensitized oxidation reactions and the photoproducts formed are not structurally alerting for genotoxicity.
Collapse
Affiliation(s)
- Théo Henriet
- Université Paris Sud
- UFR de Pharmacie
- Groupe Matériaux et Santé
- 92296 Châtenay-Malabry
- France
| | | | - Fatma Amrani
- Université Paris Sud
- UFR de Pharmacie
- Groupe Matériaux et Santé
- 92296 Châtenay-Malabry
- France
| | - Hassane Sadou-Yayé
- Université Paris Sud
- UFR de Pharmacie
- Groupe Matériaux et Santé
- 92296 Châtenay-Malabry
- France
| | - Mélisande Bernard
- Université Paris Sud
- UFR de Pharmacie
- Groupe Matériaux et Santé
- 92296 Châtenay-Malabry
- France
| | - Audrey Solgadi
- Université Paris-Sud
- UFR de Pharmacie
- SAMM – Service d'Analyse des Médicaments et Métabolites
- Institut d'Innovation Thérapeutique
- 92296 Châtenay-Malabry
| | - Najet Yagoubi
- Université Paris Sud
- UFR de Pharmacie
- Groupe Matériaux et Santé
- 92296 Châtenay-Malabry
- France
| | - Bernard Do
- Université Paris Sud
- UFR de Pharmacie
- Groupe Matériaux et Santé
- 92296 Châtenay-Malabry
- France
| |
Collapse
|
30
|
Moulin M, Solgadi A, Veksler V, Garnier A, Ventura-Clapier R, Chaminade P. Sex-specific cardiac cardiolipin remodelling after doxorubicin treatment. Biol Sex Differ 2015; 6:20. [PMID: 26478810 PMCID: PMC4608149 DOI: 10.1186/s13293-015-0039-5] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/14/2015] [Accepted: 10/06/2015] [Indexed: 01/25/2023] Open
Abstract
Background Imbalance in lipid metabolism and membrane lipid homeostasis has been observed in numerous diseases including heart failure and cardiotoxicity. Growing evidence links phospholipid alterations especially cardiolipins (CLs) to defects in mitochondrial function and energy metabolism in heart failure. We have shown recently that doxorubicin cardiotoxicity is more severe in male than female Wistar rats. We aimed to study whether this sex specificity is linked to differences in cardiac phospholipid profiles. Results Adult male and female rats were injected 2 mg/kg doxorubicin weekly for 7 weeks. Cardiac phospholipid molecular species were determined by liquid chromatography coupled with mass spectrometry fragmentation (LC)/MSn. Sex difference in phosphatidylethanolamine and phosphatidylcholine species containing docosahexaenoic and docosapentaenoic acyl chains was observed, females having more than males. In both sexes, doxorubicin induced an important loss of the main CL(18:2)4, while the level of monolysocardiolipin MLCL(18:2)3 remained stable. However, a severe remodelling appeared in treated rats with the longest CL acyl chains in doxorubicin-treated females, which might compensate for the loss of tetra-linoleoyl CL. The level of oxidized cardiolipin was not particularly increased after doxorubicin treatment. Finally, expression of genes involved in the biosynthesis of fatty acid appeared to be decreased in doxorubicin-treated males. Conclusions These results emphasize for the first time the cardiac remodelling in the phospholipid classes after doxorubicin treatment. These observations suggest that doxorubicin has a sex-specific impact on the heart phospholipidome especially on cardiolipin, an essential mitochondrial lipid. Further studies are needed to better understand the roles of lipids in the anthracycline cardiotoxicity and sex differences, but phospholipid cardioprotection seems a valuable new additive therapeutic strategy for anthracycline cardiotoxicity. Electronic supplementary material The online version of this article (doi:10.1186/s13293-015-0039-5) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Maryline Moulin
- UMR-S 1180, Inserm, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France ; Current address: Université Paris Diderot, Unité de Biologie Fonctionnelle et Adaptative, CNRS UMR 8251, Paris, France
| | - Audrey Solgadi
- SFR IPSIT (Institut Paris-Saclay d'Innovation Thérapeutique), Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France ; UMS IPSIT Service d'Analyse des Médicaments et Métabolites, Châtenay-Malabry, France
| | - Vladimir Veksler
- UMR-S 1180, Inserm, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France
| | - Anne Garnier
- UMR-S 1180, Inserm, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France
| | - Renée Ventura-Clapier
- UMR-S 1180, Inserm, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France
| | - Pierre Chaminade
- SFR IPSIT (Institut Paris-Saclay d'Innovation Thérapeutique), Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France ; UMS IPSIT Service d'Analyse des Médicaments et Métabolites, Châtenay-Malabry, France ; Lip(Sys)2 ex EA4041, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France
| |
Collapse
|
31
|
Secrétan PH, Sadou-Yayé H, Aymes-Chodur C, Bernard M, Solgadi A, Amrani F, Yagoubi N, Do B. A comprehensive study of apixaban's degradation pathways under stress conditions using liquid chromatography coupled to multistage mass spectrometry. RSC Adv 2015. [DOI: 10.1039/c5ra00171d] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
The main degradation pathways of apixaban, a novel anticoagulant drug acting as factor Xa inhibitor, has been established based on the degradation products identification using liquid chromatography coupled to multistage high resolution mass spectrometry.
Collapse
Affiliation(s)
- Philippe-Henri Secrétan
- Université Paris Sud
- UFR de Pharmacie, Groupe Matériaux et Santé
- Institut d'Innovation Thérapeutique
- France
| | - Hassane Sadou-Yayé
- Université Paris Sud
- UFR de Pharmacie, Groupe Matériaux et Santé
- Institut d'Innovation Thérapeutique
- France
- Assistance Publique-Hôpitaux de Paris
| | - Caroline Aymes-Chodur
- Université Paris Sud
- UFR de Pharmacie, Groupe Matériaux et Santé
- Institut d'Innovation Thérapeutique
- France
| | - Mélisande Bernard
- Université Paris Sud
- UFR de Pharmacie, Groupe Matériaux et Santé
- Institut d'Innovation Thérapeutique
- France
- Assistance Publique-Hôpitaux de Paris
| | - Audrey Solgadi
- Université Paris-Sud
- UFR de Pharmacie
- SAMM – Service d'Analyse des Médicaments et Métabolites
- Institut d'Innovation Thérapeutique
- France
| | - Fatma Amrani
- Assistance Publique-Hôpitaux de Paris
- Agence Générale des Equipements et Produits de Santé
- Département de Contrôle Qualité et Développement Analytique
- 75005 Paris
- France
| | - Najet Yagoubi
- Université Paris Sud
- UFR de Pharmacie, Groupe Matériaux et Santé
- Institut d'Innovation Thérapeutique
- France
| | - Bernard Do
- Université Paris Sud
- UFR de Pharmacie, Groupe Matériaux et Santé
- Institut d'Innovation Thérapeutique
- France
- Assistance Publique-Hôpitaux de Paris
| |
Collapse
|
32
|
Amrani F, Secrétan PH, Sadou-Yayé H, Aymes-Chodur C, Bernard M, Solgadi A, Yagoubi N, Do B. Identification of dabigatran etexilate major degradation pathways by liquid chromatography coupled to multi stage high-resolution mass spectrometry. RSC Adv 2015. [DOI: 10.1039/c5ra04251h] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
The major degradation mechanisms of dabigatran etexilate were deduced in the context of stress testing. Under hydrolytic stress conditions, O-dealkylation may occur along with formation of benzimidic acid derivatives.
Collapse
Affiliation(s)
- Fatma Amrani
- Université Paris-Saclay
- UFR de Pharmacie
- Groupe Matériaux et Santé
- Institut d'Innovation Thérapeutique
- 92296 Châtenay-Malabry
| | - Philippe-Henri Secrétan
- Université Paris-Saclay
- UFR de Pharmacie
- Groupe Matériaux et Santé
- Institut d'Innovation Thérapeutique
- 92296 Châtenay-Malabry
| | - Hassane Sadou-Yayé
- Université Paris-Saclay
- UFR de Pharmacie
- Groupe Matériaux et Santé
- Institut d'Innovation Thérapeutique
- 92296 Châtenay-Malabry
| | - Caroline Aymes-Chodur
- Université Paris-Saclay
- UFR de Pharmacie
- Groupe Matériaux et Santé
- Institut d'Innovation Thérapeutique
- 92296 Châtenay-Malabry
| | - Mélisande Bernard
- Université Paris-Saclay
- UFR de Pharmacie
- Groupe Matériaux et Santé
- Institut d'Innovation Thérapeutique
- 92296 Châtenay-Malabry
| | - Audrey Solgadi
- Université Paris-Saclay
- UFR de Pharmacie
- SAMM – Service d'Analyse des Médicaments et Métabolites
- Institut d'Innovation Thérapeutique
- 92296 Châtenay-Malabry
| | - Najet Yagoubi
- Université Paris-Saclay
- UFR de Pharmacie
- Groupe Matériaux et Santé
- Institut d'Innovation Thérapeutique
- 92296 Châtenay-Malabry
| | - Bernard Do
- Université Paris-Saclay
- UFR de Pharmacie
- Groupe Matériaux et Santé
- Institut d'Innovation Thérapeutique
- 92296 Châtenay-Malabry
| |
Collapse
|
33
|
Moulin M, Piquereau J, Mateo P, Fortin D, Rucker-Martin C, Gressette M, Lefebvre F, Gresikova M, Solgadi A, Veksler V, Garnier A, Ventura-Clapier R. Sexual Dimorphism of Doxorubicin-Mediated Cardiotoxicity. Circ Heart Fail 2015; 8:98-108. [DOI: 10.1161/circheartfailure.114.001180] [Citation(s) in RCA: 77] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Background—
Cardiovascular diseases are the major cause of mortality among both men and women with a lower incidence in women before menopause. The clinical use of doxorubicin, widely used as an antineoplastic agent, is markedly hampered by severe cardiotoxicity. Even if there is a significant sex difference in incidence of cardiovascular disease at the adult stage, it is not known whether a difference in doxorubicin-related cardiotoxicity between men and women also exists. The objective of this work was to explore the cardiac side effects of doxorubicin in adult rats and decipher whether signaling pathways involved in cardiac toxicity differ between sexes.
Methods and Results—
After 7 weeks of doxorubicin (2 mg/kg per week), males developed major signs of cardiomyopathy with cardiac atrophy, reduced left ventricular ejection fraction and 50% mortality. In contrast, no female died and their left ventricular ejection fraction was only moderately affected. Surprisingly, neither global oxidation levels nor the antioxidant response nor the apoptosis signaling pathways were altered by doxorubicin. However, the level of total adenosine monophosphate–activated protein kinase was severely decreased only in males. Moreover, markers of mitochondrial biogenesis and cardiolipin content were strongly reduced only in males. To analyze the onset of the pathology, maximal oxygen consumption rate of left ventricular permeabilized fibers after 4 weeks of treatment was reduced only in doxorubicin-treated males.
Conclusions—
Altogether, these results clearly evidence sex differences in doxorubicin toxicity. Cardiac mitochondrial dysfunction and adenosine monophosphate–activated protein kinase seem as critical sites of sex differences in cardiotoxicity as evidenced by significant statistical interactions between sex and treatment effects.
Collapse
Affiliation(s)
- Maryline Moulin
- From the INSERM UMR-S 769, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., M.G., F.L., M.G., V.V., A.G., R.V.-C.); IPSIT-IFR141 Université de Paris-Sud, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., C.R.-M., M.G., F.L., M.G., A.S., V.V., A.G., R.V.-C.); INSERM UMR-S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France (C.R.-M.); and IPSIT-IFR141 Service d’Analyse des Médicaments et Métabolites, Châtenay-Malabry, France (A.S.)
| | - Jérôme Piquereau
- From the INSERM UMR-S 769, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., M.G., F.L., M.G., V.V., A.G., R.V.-C.); IPSIT-IFR141 Université de Paris-Sud, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., C.R.-M., M.G., F.L., M.G., A.S., V.V., A.G., R.V.-C.); INSERM UMR-S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France (C.R.-M.); and IPSIT-IFR141 Service d’Analyse des Médicaments et Métabolites, Châtenay-Malabry, France (A.S.)
| | - Philippe Mateo
- From the INSERM UMR-S 769, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., M.G., F.L., M.G., V.V., A.G., R.V.-C.); IPSIT-IFR141 Université de Paris-Sud, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., C.R.-M., M.G., F.L., M.G., A.S., V.V., A.G., R.V.-C.); INSERM UMR-S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France (C.R.-M.); and IPSIT-IFR141 Service d’Analyse des Médicaments et Métabolites, Châtenay-Malabry, France (A.S.)
| | - Dominique Fortin
- From the INSERM UMR-S 769, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., M.G., F.L., M.G., V.V., A.G., R.V.-C.); IPSIT-IFR141 Université de Paris-Sud, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., C.R.-M., M.G., F.L., M.G., A.S., V.V., A.G., R.V.-C.); INSERM UMR-S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France (C.R.-M.); and IPSIT-IFR141 Service d’Analyse des Médicaments et Métabolites, Châtenay-Malabry, France (A.S.)
| | - Catherine Rucker-Martin
- From the INSERM UMR-S 769, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., M.G., F.L., M.G., V.V., A.G., R.V.-C.); IPSIT-IFR141 Université de Paris-Sud, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., C.R.-M., M.G., F.L., M.G., A.S., V.V., A.G., R.V.-C.); INSERM UMR-S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France (C.R.-M.); and IPSIT-IFR141 Service d’Analyse des Médicaments et Métabolites, Châtenay-Malabry, France (A.S.)
| | - Mélanie Gressette
- From the INSERM UMR-S 769, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., M.G., F.L., M.G., V.V., A.G., R.V.-C.); IPSIT-IFR141 Université de Paris-Sud, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., C.R.-M., M.G., F.L., M.G., A.S., V.V., A.G., R.V.-C.); INSERM UMR-S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France (C.R.-M.); and IPSIT-IFR141 Service d’Analyse des Médicaments et Métabolites, Châtenay-Malabry, France (A.S.)
| | - Florence Lefebvre
- From the INSERM UMR-S 769, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., M.G., F.L., M.G., V.V., A.G., R.V.-C.); IPSIT-IFR141 Université de Paris-Sud, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., C.R.-M., M.G., F.L., M.G., A.S., V.V., A.G., R.V.-C.); INSERM UMR-S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France (C.R.-M.); and IPSIT-IFR141 Service d’Analyse des Médicaments et Métabolites, Châtenay-Malabry, France (A.S.)
| | - Milada Gresikova
- From the INSERM UMR-S 769, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., M.G., F.L., M.G., V.V., A.G., R.V.-C.); IPSIT-IFR141 Université de Paris-Sud, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., C.R.-M., M.G., F.L., M.G., A.S., V.V., A.G., R.V.-C.); INSERM UMR-S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France (C.R.-M.); and IPSIT-IFR141 Service d’Analyse des Médicaments et Métabolites, Châtenay-Malabry, France (A.S.)
| | - Audrey Solgadi
- From the INSERM UMR-S 769, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., M.G., F.L., M.G., V.V., A.G., R.V.-C.); IPSIT-IFR141 Université de Paris-Sud, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., C.R.-M., M.G., F.L., M.G., A.S., V.V., A.G., R.V.-C.); INSERM UMR-S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France (C.R.-M.); and IPSIT-IFR141 Service d’Analyse des Médicaments et Métabolites, Châtenay-Malabry, France (A.S.)
| | - Vladimir Veksler
- From the INSERM UMR-S 769, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., M.G., F.L., M.G., V.V., A.G., R.V.-C.); IPSIT-IFR141 Université de Paris-Sud, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., C.R.-M., M.G., F.L., M.G., A.S., V.V., A.G., R.V.-C.); INSERM UMR-S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France (C.R.-M.); and IPSIT-IFR141 Service d’Analyse des Médicaments et Métabolites, Châtenay-Malabry, France (A.S.)
| | - Anne Garnier
- From the INSERM UMR-S 769, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., M.G., F.L., M.G., V.V., A.G., R.V.-C.); IPSIT-IFR141 Université de Paris-Sud, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., C.R.-M., M.G., F.L., M.G., A.S., V.V., A.G., R.V.-C.); INSERM UMR-S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France (C.R.-M.); and IPSIT-IFR141 Service d’Analyse des Médicaments et Métabolites, Châtenay-Malabry, France (A.S.)
| | - Renée Ventura-Clapier
- From the INSERM UMR-S 769, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., M.G., F.L., M.G., V.V., A.G., R.V.-C.); IPSIT-IFR141 Université de Paris-Sud, Châtenay-Malabry, France (M.M., J.P., P.M., D.F., C.R.-M., M.G., F.L., M.G., A.S., V.V., A.G., R.V.-C.); INSERM UMR-S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France (C.R.-M.); and IPSIT-IFR141 Service d’Analyse des Médicaments et Métabolites, Châtenay-Malabry, France (A.S.)
| |
Collapse
|
34
|
Bony NF, Libong D, Solgadi A, Bleton J, Champy P, Malan AK, Chaminade P. Establishing high temperature gas chromatographic profiles of non-polar metabolites for quality assessment of African traditional herbal medicinal products. J Pharm Biomed Anal 2014; 88:542-51. [DOI: 10.1016/j.jpba.2013.10.013] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2013] [Revised: 09/30/2013] [Accepted: 10/07/2013] [Indexed: 11/25/2022]
|
35
|
Coimbra ES, Libong D, Cojean S, Saint-Pierre-Chazalet M, Solgadi A, Le Moyec L, Duenas-Romero AM, Chaminade P, Loiseau PM. Mechanism of interaction of sitamaquine with Leishmania donovani. J Antimicrob Chemother 2010; 65:2548-55. [PMID: 20956354 DOI: 10.1093/jac/dkq371] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVES This study focuses on the mechanism of interaction of sitamaquine with Leishmania donovani membranes, and its accumulation within the parasites. METHODS A biomimetic model of the outer layer of a Leishmania plasma membrane was used to examine the interactions of sitamaquine with lipids. The plasma membranes of L. donovani promastigotes were depleted of sterol using cholesterol oxidase, in order to assess the importance of sterols in drug-membrane interactions. Sterols were quantified and sitamaquine susceptibility was assessed using the MTT test. Kinetics of sitamaquine accumulation and efflux were measured under different conditions. RESULTS Sitamaquine interacts first with phospholipid anionic polar head groups and then with phospholipid acyl chains to insert within biological membranes and accumulates rapidly in the Leishmania cytosol according to a sterol-independent process. The rapid sitamaquine efflux observed was related to an energy-dependent mechanism since the intracellular amount of sitamaquine was enhanced three times in the absence of glucose and the efflux was inhibited in energy-depleted conditions. (1)H NMR analysis of motile lipid showed that sitamaquine did not affect lipid trafficking in Leishmania. CONCLUSIONS We propose that sitamaquine rapidly accumulates in Leishmania by diffusion along an electrical gradient and is concentrated in the cytosol by an energy- and sterol-independent process. The affinity of sitamaquine for membranes was transitory and an energy-dependent efflux was demonstrated, suggesting the presence of an as yet uncharacterized transporter.
Collapse
Affiliation(s)
- E S Coimbra
- Université Paris-Sud, UMR 8076, Chimiothérapie Antiparasitaire, Faculté de Pharmacie, Chatenay-Malabry, France
| | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Karolak S, Nefau T, Bailly E, Solgadi A, Levi Y. Estimation of illicit drugs consumption by wastewater analysis in Paris area (France). Forensic Sci Int 2010; 200:153-60. [DOI: 10.1016/j.forsciint.2010.04.007] [Citation(s) in RCA: 110] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2009] [Revised: 03/31/2010] [Accepted: 04/08/2010] [Indexed: 11/27/2022]
|
37
|
Solgadi A, Jean L, Lasne MC, Rouden J, Courtieu J, Meddour A. NMR in chiral polypeptide liquid crystals: the problem of amines. ACTA ACUST UNITED AC 2007. [DOI: 10.1016/j.tetasy.2007.06.018] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
38
|
|